[{"status": "Ongoing", "city": "Allentown", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA016733"], "brand_name": ["SODIUM CHLORIDE FOR IRRIGATION"], "generic_name": ["SODIUM CHLORIDE FOR IRRIGATION"], "manufacturer_name": ["B. Braun Medical Inc."], "product_ndc": ["0264-7388"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["IRRIGATION"], "substance_name": ["SODIUM CHLORIDE"], "rxcui": ["486515"], "spl_id": ["69f7d8f6-65cd-45bd-83f7-7249905a2e72"], "spl_set_id": ["5bd9b176-0402-4a3f-a6b4-c3f393fc092a"], "package_ndc": ["0264-7388-50", "0264-7388-60"], "is_original_packager": [true], "unii": ["451W47IQ8X"]}, "product_type": "Drugs", "event_id": "97477", "recalling_firm": "B BRAUN MEDICAL INC", "address_1": "861 Marcon Blvd", "address_2": "N/A", "postal_code": "18109-9577", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0653-2025", "product_description": "0.9% SODIUM CHLORIDE IRRIGATION USP. ISOTONIC SOLUTION FOR IRRIGATION, 3000mL, Rx only, B. Braun Medical Inc., Bethlehem, PA, 18018, USA, NDC 0264-7388-60.", "product_quantity": "16,228 3000 mL bags", "reason_for_recall": "Lack of Assurance of Sterility- Potential for fluid leakage from the port due to port misalignment.", "recall_initiation_date": "20250826", "center_classification_date": "20250916", "report_date": "20250924", "code_info": "Lot#: : J4C521, J4C516, J4C524, Exp. : 28FEB2027."}, {"status": "Ongoing", "city": "Lakewood", "state": "CO", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96792", "recalling_firm": "BSO LLC", "address_1": "12860 W Cedar Dr Ste 211", "address_2": "N/A", "postal_code": "80228-1971", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0412-2025", "product_description": "TESTOSTERONE PELLET 100 mg (with Cholesterol </=4%), 1 Pellet for Subcutaneous Use, This is a Compounded Drug, Not for Resale, RX or Office Use Only, Belmar Select Outsources, 12860 W. Cedar Drive #211, Lakewood, CO 80228, NDC: 70168-0101-01", "product_quantity": "2,762 vials", "reason_for_recall": "Presence of Particulate Matter: Glass particles were found in pellet vials.", "recall_initiation_date": "20250428", "center_classification_date": "20250506", "report_date": "20250514", "code_info": "Lot 20250102@6, exp 12/11/2025; Lot 20250130@4, exp 1/22/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Englewood", "state": "CO", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96742", "recalling_firm": "Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado)", "address_1": "88 Inverness Cir E Unit A204", "address_2": "", "postal_code": "80112-5521", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "USA Nationwide", "recall_number": "D-0482-2025", "product_description": "Tirzepatide Injections, 10mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewood, CO 80112", "product_quantity": "24 syringes", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20250521", "center_classification_date": "20250620", "report_date": "20250702", "code_info": "Lot, expiry:   H272962, exp 12/5/2025; S5045185, exp 5/20/2025;  H272962, exp 12/5/2025;  H270625, exp 9/30/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Chattanooga", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96552", "recalling_firm": "Chattem Inc", "address_1": "1715 W 38th St", "address_2": "", "postal_code": "37409-1248", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "", "distribution_pattern": "Nationwide.", "recall_number": "D-0362-2025", "product_description": "Unisom, SleepMinis, Diphenhydramine HCl, Mini-Capsules, 25 mg, 60 Mini-Capsules bottles, Dist. by Chattem, Inc., P.O. Box 2219, Chattanooga, TN 37409-0219, USA, UPC 0 41167 00670 2", "product_quantity": "129,240 bottles", "reason_for_recall": "CGMP Deviations; detection of Nitrosamine Drug Substance-Related Impurities (NDSRI), N-nitroso-desmethyl-diphenhydramine (n-dph), above the FDA Recommended Intake Limit", "recall_initiation_date": "20250326", "center_classification_date": "20250411", "report_date": "20250423", "code_info": "LOT 22L603, EXP: Oct 2025; LOT 378999, EXP: Feb 2027", "more_code_info": ""}, {"status": "Ongoing", "city": "Bridgewater", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA209755"], "brand_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "generic_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "manufacturer_name": ["Amneal Pharmaceuticals NY LLC"], "product_ndc": ["69238-1054", "69238-1056", "69238-1058", "69238-1060", "69238-1062"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "rxcui": ["991039", "991044", "991188", "991194", "991336"], "spl_id": ["8c2ad75b-ee8b-4f55-b77f-c23a1a7cf5a2"], "spl_set_id": ["aa086a21-de85-4b03-af58-49b70acf8cf0"], "package_ndc": ["69238-1054-1", "69238-1056-1", "69238-1058-1", "69238-1060-1", "69238-1062-1"], "is_original_packager": [true], "upc": ["0369238105612", "0369238106213"], "unii": ["9WP59609J6"]}, "product_type": "Drugs", "event_id": "97438", "recalling_firm": "Amneal Pharmaceuticals, LLC", "address_1": "400 Crossing Blvd Fl 3", "address_2": "N/A", "postal_code": "08807-2863", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0618-2025", "product_description": "chlorproMAZINE Hydrochloride Tablets, USP, 100 mg, 100-count  bottle, Rx Only, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd., Oral Solid Dosage Unit, Ahmedabad 382213, INDIA; Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807, NDC 69238-1060-1.", "product_quantity": "14,923 100-count bottles", "reason_for_recall": "Presence of a foreign substance.A specific lot of auxiliary polyester coil, used in product packaging was   detected with presence of a micro-organism. No micro-organism was detected on any tablets.", "recall_initiation_date": "20250818", "center_classification_date": "20250904", "report_date": "20250910", "code_info": "Lot: AM240334, AM240335, Exp Date 02/28/2027, AM241031, Exp Date 06/30/2027."}, {"status": "Ongoing", "city": "Pennington", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA213368"], "brand_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "generic_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "manufacturer_name": ["Northstar Rx LLC"], "product_ndc": ["16714-047", "16714-048", "16714-049", "16714-050", "16714-051"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "rxcui": ["991039", "991044", "991188", "991194", "991336"], "spl_id": ["13fe8f97-37e8-4d10-87fe-e1d17f4f23d8"], "spl_set_id": ["2bd42d3a-bf89-4d74-a252-9b914106a570"], "package_ndc": ["16714-047-01", "16714-048-01", "16714-049-01", "16714-050-01", "16714-051-01"], "is_original_packager": [true], "unii": ["9WP59609J6"]}, "product_type": "Drugs", "event_id": "97534", "recalling_firm": "Zydus Pharmaceuticals (USA) Inc", "address_1": "73 Route 31 N", "address_2": "N/A", "postal_code": "08534-3601", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0639-2025", "product_description": "Chlorpromazine Hydrochloride Tablets, USP, 200 mg, 100-count bottle, Rx only, Manufactured By: Zydus Lifesciences Ltd., Baddi, India; Manufactured for: Northstar Rx LLC Memphis, TN 38141.  NDC: 16714-051-01", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit", "recall_initiation_date": "20250903", "center_classification_date": "20250910", "report_date": "20250917", "code_info": "Lot #: Z305085, Exp Date 30-09-25; Z401166, Z401167, Exp Date 28-02-26"}, {"status": "Ongoing", "city": "Bridgewater", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA209755"], "brand_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "generic_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "manufacturer_name": ["Amneal Pharmaceuticals NY LLC"], "product_ndc": ["69238-1054", "69238-1056", "69238-1058", "69238-1060", "69238-1062"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "rxcui": ["991039", "991044", "991188", "991194", "991336"], "spl_id": ["8c2ad75b-ee8b-4f55-b77f-c23a1a7cf5a2"], "spl_set_id": ["aa086a21-de85-4b03-af58-49b70acf8cf0"], "package_ndc": ["69238-1054-1", "69238-1056-1", "69238-1058-1", "69238-1060-1", "69238-1062-1"], "is_original_packager": [true], "upc": ["0369238105612", "0369238106213"], "unii": ["9WP59609J6"]}, "product_type": "Drugs", "event_id": "97438", "recalling_firm": "Amneal Pharmaceuticals, LLC", "address_1": "400 Crossing Blvd Fl 3", "address_2": "N/A", "postal_code": "08807-2863", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0616-2025", "product_description": "chlorproMAZINE Hydrochloride Tablets, USP, 25 mg, 100-count bottles, Rx Only, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd., Oral Solid Dosage Unit, Ahmedabad 382213, INDIA, Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807, NDC 69238-1056-1.", "product_quantity": "7,228 100-count bottles", "reason_for_recall": "Presence of a foreign substance.A specific lot of auxiliary polyester coil, used in product packaging was   detected with presence of a micro-organism. No micro-organism was detected on any tablets.", "recall_initiation_date": "20250818", "center_classification_date": "20250904", "report_date": "20250910", "code_info": "Lot AM240617, AM240618, Exp Date 04/30/2027"}, {"status": "Ongoing", "city": "Mumbai", "state": "N/A", "country": "India", "classification": "Class III", "openfda": {"application_number": ["ANDA201022"], "brand_name": ["FAMCICLOVIR"], "generic_name": ["FAMCICLOVIR"], "manufacturer_name": ["Macleods Pharmaceuticals Limited"], "product_ndc": ["33342-024", "33342-025", "33342-026"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["FAMCICLOVIR"], "rxcui": ["198382", "199192", "199193"], "spl_id": ["b783e311-5fb2-4ab3-b10a-36c87c2a7d5f"], "spl_set_id": ["eeeee9c4-8566-4100-8ca4-3df936a3365d"], "package_ndc": ["33342-024-07", "33342-025-07", "33342-026-07"], "is_original_packager": [true], "upc": ["0333342026071", "0333342024077", "0333342025074"], "nui": ["N0000020060", "N0000180187", "N0000175459"], "pharm_class_moa": ["DNA Polymerase Inhibitors [MoA]"], "pharm_class_epc": ["Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]"], "unii": ["QIC03ANI02"]}, "product_type": "Drugs", "event_id": "97058", "recalling_firm": "Macleods Pharmaceuticals Ltd", "address_1": "304 Atlanta Arcade", "address_2": "Church Road", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide.", "recall_number": "D-0509-2025", "product_description": "Famciclovir Tablets, USP 500 mg, 30-count bottles, Rx Only, Manufactured for: Macleods Pharma USA, Inc., Manufactured by: Macleods Pharmaceuticals Ltd., Daman, India NDC# 33342-026-07.", "product_quantity": "9,888/ 30 count bottles", "reason_for_recall": "Presence of Foreign Substance- Black hair strand found attached to a tablet in a sealed bottle.", "recall_initiation_date": "20250611", "center_classification_date": "20250707", "report_date": "20250716", "code_info": "Lot # 12250247B, Exp. 01/31/2027", "more_code_info": ""}, {"status": "Ongoing", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA210207"], "brand_name": ["CINACALCET HYDROCHLORIDE"], "generic_name": ["CINACALCET HYDROCHLORIDE"], "manufacturer_name": ["Slate Run Pharmaceuticals"], "product_ndc": ["70436-007", "70436-008", "70436-009"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CINACALCET HYDROCHLORIDE"], "rxcui": ["432400", "432401", "432402"], "spl_id": ["bd9ce3c3-15d0-454a-8546-58fa06c3bea7"], "spl_set_id": ["0850ec78-ae46-481e-a6b5-8169cb843eab"], "package_ndc": ["70436-007-04", "70436-008-04", "70436-009-04"], "is_original_packager": [true], "upc": ["0370436009046"], "unii": ["1K860WSG25"]}, "product_type": "Drugs", "event_id": "96433", "recalling_firm": "Slate Run Pharmaceuticals", "address_1": "277 W Nationwide Blvd Ste 260", "address_2": "N/A", "postal_code": "43215-0169", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to 8 distributors who may have further distribute the product nationwide.", "recall_number": "D-0279-2025", "product_description": "Cinacalcet Hydrochloride Tablets 60 mg, 30-count bottle, Rx only, Distr. by: Slate Run Pharma., LLC, Columbus, Ohio 43215, Mfg. by: Piramal Pharma Limited, Madhya Pradesh, India, NDC 70436-008-04", "product_quantity": "2,444 bottles", "reason_for_recall": "CGMP deviations: The presence of nitrosamine impurity above the acceptable daily intake limits.", "recall_initiation_date": "20250307", "center_classification_date": "20250317", "report_date": "20250326", "code_info": "Lot # 109797, Exp 11/2026"}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA205006"], "brand_name": ["LACOSAMIDE"], "generic_name": ["LACOSAMIDE"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc. USA"], "product_ndc": ["68462-678", "68462-679", "68462-680", "68462-681"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LACOSAMIDE"], "rxcui": ["809987", "809992", "809996", "810000"], "spl_id": ["a65056ce-b6e9-4bed-adbd-98052a2e705e"], "spl_set_id": ["df1d2e6a-6129-49c9-b2c1-0fdf73f38b9c"], "package_ndc": ["68462-678-30", "68462-678-60", "68462-678-10", "68462-679-30", "68462-679-60", "68462-679-10", "68462-680-30", "68462-680-60", "68462-680-10", "68462-681-30", "68462-681-60", "68462-681-10"], "is_original_packager": [true], "upc": ["0368462680605", "0368462681602"], "nui": ["N0000008486"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "unii": ["563KS2PQY5"]}, "product_type": "Drugs", "event_id": "96474", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0330-2025", "product_description": "Lacosamide Tablets, 100mg , 60-count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India, Manufactured for: Glenmark Pharmaceuticals Inc. USA, Mahwah, NJ 07430. NDC# 68462-679-60", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250313", "center_classification_date": "20250408", "report_date": "20250416", "code_info": "Lot #  17232533, exp. date Nov-25 17232534, exp. date Nov-25 17240606, exp. date Mar-26 17240619, exp. date Mar-26 17240911, exp. date May-26 17240912, exp. date May-26 17241121, exp. date Jun-26 17241124, exp. date Jun-26"}, {"status": "Ongoing", "city": "Kirkland", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95836", "recalling_firm": "Jubilant Draximage Inc., dba Jubilant Radiopharma", "address_1": "16751 Rte Transcanadienne", "address_2": "", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "US Nationwide.", "recall_number": "D-0191-2025", "product_description": "Kit for the Preparation of Technetium Tc 99m Sulfur Colloid Injection, 10 mL Multi-Dose Reaction Vial, 5 vial Box, Rx Only, Manufactured for: Jubilant Draximage Inc., dba Jubilant Radiopharma, Kirkland , Quebec, H9H, 4J$, Canada, NDC# 65174-179-05.", "product_quantity": "5209 kits", "reason_for_recall": "Failed Stability Specifications", "recall_initiation_date": "20241122", "center_classification_date": "20250108", "report_date": "20250115", "code_info": "LOT C2300070 and C2300070E;Exp. May 31, 2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Ta. Kadi, District Mehsana", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {"application_number": ["M017"], "brand_name": ["ARTRIDON"], "generic_name": ["MENTHOL, METHYL SALICYLATE"], "manufacturer_name": ["Pharmadel LLC"], "product_ndc": ["55758-030"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["MENTHOL, UNSPECIFIED FORM", "METHYL SALICYLATE"], "spl_id": ["25a37e66-e7e1-90bc-e063-6394a90ae964"], "spl_set_id": ["73572156-4cce-0669-e053-2991aa0aaecc"], "package_ndc": ["55758-030-05"], "is_original_packager": [true], "unii": ["L7T10EIP3A", "LAV5U5022Y"], "upc": ["810096771513"]}, "product_type": "Drugs", "event_id": "96797", "recalling_firm": "KENIL HEALTHCARE PRIVATE LIMITED", "address_1": "Plot 319", "address_2": "Village Acharasan, Ankhol-Vamaj Road", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "DE and NC", "recall_number": "D-0421-2025", "product_description": "Artridon Glucosamine (menthol 2% and Methyl Salicylate 15% - Topical Analgesic), for arthritis joint pain relief, 5 oz (142g) Tube, Dist by/por: Pharmadel LLC, New Castle, DE, 19720, Made in India, NDC 55758-030-05, UPC 8 10096 77151 3.", "product_quantity": "9,984 Tubes", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250424", "center_classification_date": "20250519", "report_date": "20250528", "code_info": "Lot SP25A, Exp Date: 09/30/2026"}, {"status": "Ongoing", "city": "Kirkland", "state": "WA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "97292", "recalling_firm": "AEQUITA PHARMACY", "address_1": "12825 Ne 126th Pl", "address_2": "N/A", "postal_code": "98034-7721", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "MA", "recall_number": "D-0554-2025", "product_description": "Tirzepatide + Niacinamide 2.2 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2mL Multi Dose Vial, Refrigerate, Do not freeze, Aequita Pharmacy LLC, Kirkland, WA 98034.", "product_quantity": "236 vials", "reason_for_recall": "Lack of Processing Controls.", "recall_initiation_date": "20250718", "center_classification_date": "20250801", "report_date": "20250813", "code_info": "All Lots within expiry", "more_code_info": ""}, {"status": "Ongoing", "city": "La Vergne", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA213368"], "brand_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "generic_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "manufacturer_name": ["Major Pharmaceuticals"], "product_ndc": ["0904-7129", "0904-7130", "0904-7131", "0904-7132", "0904-7133"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "rxcui": ["991039", "991044", "991188", "991194", "991336"], "spl_id": ["be5824c1-1eca-44db-a689-c67b9808c1f9"], "spl_set_id": ["d58570a0-58b0-4662-b2ad-aa8d1463b4c1"], "package_ndc": ["0904-7129-61", "0904-7130-61", "0904-7130-06", "0904-7131-61", "0904-7132-61", "0904-7133-61", "0030904713"], "original_packager_product_ndc": ["70710-1129", "70710-1130", "70710-1131", "70710-1132", "70710-1133"], "unii": ["9WP59609J6"], "upc": ["003090471316"]}, "product_type": "Drugs", "event_id": "97584", "recalling_firm": "The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories", "address_1": "341 Mason Rd", "address_2": "", "postal_code": "37086-3606", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0011-2026", "product_description": "Major ChlorproMAZINE Hydrochloride Tablets, USP, 50 mg, 100 Tablets, (10x10) blister package, Rx Only, Packaged and Distributed by Major Pharmaceuticals, Indianapolis, IN 46268, USA, NDC 0904-7131-61, UPC (01)00309047131617", "product_quantity": "506 blister packs", "reason_for_recall": "CGMP Deviations: Presence of N-Nitroso Desmethyl Chlorpromazine above the recommended intake limit", "recall_initiation_date": "20250912", "center_classification_date": "20251007", "report_date": "20251015", "code_info": "Lots N02009 & N02026, exp. date 02/28/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Ta. Kadi, District Mehsana", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {"application_number": ["M017"], "brand_name": ["RAPIDOL"], "generic_name": ["HYDROCORTISONE"], "manufacturer_name": ["Pharmadel LLC"], "product_ndc": ["55758-420"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["HYDROCORTISONE"], "rxcui": ["106258"], "spl_id": ["25a3aeec-2ce5-6614-e063-6294a90a2ae5"], "spl_set_id": ["19a1f1e2-bc6b-7153-e063-6294a90ab115"], "package_ndc": ["55758-420-02"], "is_original_packager": [true], "nui": ["N0000175576", "N0000175450"], "pharm_class_epc": ["Corticosteroid [EPC]"], "pharm_class_moa": ["Corticosteroid Hormone Receptor Agonists [MoA]"], "unii": ["WI4X0X7BPJ"], "upc": ["810096771582"]}, "product_type": "Drugs", "event_id": "96797", "recalling_firm": "KENIL HEALTHCARE PRIVATE LIMITED", "address_1": "Plot 319", "address_2": "Village Acharasan, Ankhol-Vamaj Road", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "DE and NC", "recall_number": "D-0428-2025", "product_description": "Rapidol Maximum Strength, Hydrocortisone 1% Anti-Itch Cream, NET WT 2 oz (60g) Tube, Distributed by: Pharmadel LLC, New Castle, DE, 19720, NDC 55758-420-02, UPC 8 10096 77158 2.", "product_quantity": "10,000 Tubes", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250424", "center_classification_date": "20250519", "report_date": "20250528", "code_info": "Lot SP26A, Exp: 09/30/2026"}, {"status": "Ongoing", "city": "Pulaski", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA207372"], "brand_name": ["NITROFURANTOIN"], "generic_name": ["NITROFURANTOIN MONOHYDRATE/MACROCRYSTALS"], "manufacturer_name": ["AvPAK"], "product_ndc": ["50268-625"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["NITROFURANTOIN", "NITROFURANTOIN MONOHYDRATE"], "rxcui": ["1648755"], "spl_id": ["0e77340b-340d-fe13-e063-6294a90a0301"], "spl_set_id": ["736b2487-e83f-d172-e053-2a91aa0ab0cf"], "package_ndc": ["50268-625-11", "50268-625-15"], "original_packager_product_ndc": ["65162-478"], "nui": ["N0000175494", "M0014892"], "pharm_class_epc": ["Nitrofuran Antibacterial [EPC]"], "pharm_class_cs": ["Nitrofurans [CS]"], "unii": ["927AH8112L", "E1QI2CQQ1I"]}, "product_type": "Drugs", "event_id": "95919", "recalling_firm": "AvKARE", "address_1": "615 N 1st St", "address_2": "", "postal_code": "38478-2403", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0168-2025", "product_description": "Nitrofurantoin Capsules, USP, 100 mg, 50 Capsules (5 x 10) Unit Dose per carton, Rx Only, Manufactured for: AvKARE, Inc., Pulaski, TN 38478.  NDC#: 50268-625-15.", "product_quantity": "1016 50-count cartons", "reason_for_recall": "Failed Dissolution Specifications", "recall_initiation_date": "20241204", "center_classification_date": "20241231", "report_date": "20250108", "code_info": "Lot # 47101; Exp. 02/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Bengaluru", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {"application_number": ["ANDA207522"], "brand_name": ["METHOCARBAMOL"], "generic_name": ["METHOCARBAMOL"], "manufacturer_name": ["Somerset Therapeutics, LLC"], "product_ndc": ["70069-101"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAVENOUS"], "substance_name": ["METHOCARBAMOL"], "rxcui": ["238175"], "spl_id": ["dd175ad9-9f83-4ef1-b745-65e44f5e12c4"], "spl_set_id": ["68dd9c24-4d41-48be-9f54-fceb787bb443"], "package_ndc": ["70069-101-25", "70069-101-10", "70069-101-05"], "is_original_packager": [true], "upc": ["0370069101018", "0370069101100", "0370069101254", "0370069101056"], "nui": ["N0000175730", "N0000175737"], "pharm_class_pe": ["Centrally-mediated Muscle Relaxation [PE]"], "pharm_class_epc": ["Muscle Relaxant [EPC]"], "unii": ["125OD7737X"]}, "product_type": "Drugs", "event_id": "96569", "recalling_firm": "Somerset Therapeutics Private Limited", "address_1": "54/1 Budihal Village", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0354-2025", "product_description": "Methocarbamol Injection USP\t1,000 mg/10 mL (100 mg/mL), 10 mL Single Dose Vial, Rx Only, Manufactured for: Somerset Therapeutics, LLC, Somerset, NJ 08873, NDC 70069-101-25 (immediate carton) and 70069-101-05 (5x10 mL carton)", "product_quantity": "506,080 vials", "reason_for_recall": "Lack of Assurance of Sterility: Media fill with bacterial contamination", "recall_initiation_date": "20250321", "center_classification_date": "20250408", "report_date": "20250416", "code_info": "NDC 70069-101-25; A240304, A240305, A240320, A240322, A240334, A240335, A240340, exp. date 05/2026;  A240342, A240347, A240385, A240391, exp. date 06/2026;   NDC 70069-101-05;  A240326, exp. date 05/2026"}, {"status": "Ongoing", "city": "Ledgewood", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "96329", "recalling_firm": "Imprimis NJOF, LLC", "address_1": "1705 Route 46 Ste 6B", "address_2": "", "postal_code": "07852-9720", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "", "distribution_pattern": "FL and NY", "recall_number": "D-0305-2025", "product_description": "Tropicamide - Proparacaine - Phenylephrine - Ketorolac Sterile Ophthalmic Solution, 1% 0.5%  2.5%  0.5%, 5 mL fill in 15 mL bottle, Imprimis NJOF, LLC, Route 46 West, Unit 6B, Ledgewood, NJ, 07852, NDC: 71384-733-05.", "product_quantity": "2822 bottles", "reason_for_recall": "Sub-Potent Drug: The stability batch showed a subpotent result, which does not meet the product specifications of 90.0-110.0% of the label claim.", "recall_initiation_date": "20250224", "center_classification_date": "20250328", "report_date": "20250409", "code_info": "Lot 24OCT041, Exp 04/26/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Panchmahal", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {"application_number": ["ANDA210560"], "brand_name": ["BROMFENAC OPHTHALMIC SOLUTION 0.09%"], "generic_name": ["BROMFENAC OPHTHALMIC SOLUTION 0.09%"], "manufacturer_name": ["Alembic Pharmaceuticals Inc."], "product_ndc": ["62332-508"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["BROMFENAC SODIUM"], "rxcui": ["578018"], "spl_id": ["824d37d0-e25f-4df8-be0e-d9a65046fc10"], "spl_set_id": ["225070ee-d862-4d41-84b8-5bd7a8a03fd7"], "package_ndc": ["62332-508-17"], "is_original_packager": [true], "unii": ["8ECV571Y37"]}, "product_type": "Drugs", "event_id": "96836", "recalling_firm": "Alembic Pharmaceuticals Limited", "address_1": "Formulation Division, Village Panelav, P.O. Tajpura, Near Baska, Taluka Halol", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "US Nationwide", "recall_number": "D-0447-2025", "product_description": "Bromfenac Ophthalmic Solution 0.09%, 1.7 mL bottle, Rx only, Sterile, Manufactured for: Alembic Pharmaceuticals, Inc., Bedminster, NJ 07921, USA, Manufactured by Alembic Pharmaceuticals Limitied, Gujarat, India, Made in India, NDC 62332-508-17", "product_quantity": "N/A", "reason_for_recall": "Failed Impurities/Degradation Specifications", "recall_initiation_date": "20250507", "center_classification_date": "20250527", "report_date": "20250604", "code_info": "Lot 7230309, Exp Date: 5/31/2025; Lot 7230310, Exp Date: 5/31/2025; Lot 7230311, Exp Date: 5/31/2025"}, {"status": "Ongoing", "city": "New Albany", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA090534"], "brand_name": ["NICARDIPINE HYDROCHLORIDE"], "generic_name": ["NICARDIPINE HYDROCHLORIDE"], "manufacturer_name": ["Civica, Inc."], "product_ndc": ["72572-470"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["NICARDIPINE HYDROCHLORIDE"], "rxcui": ["858607"], "spl_id": ["fba70df6-5d37-4a12-bce3-e6fb1b0c72b2"], "spl_set_id": ["30fb3a4d-fa75-42fd-b4b6-2a21f202027f"], "package_ndc": ["72572-470-01", "72572-470-10"], "is_original_packager": [true], "unii": ["K5BC5011K3"]}, "product_type": "Drugs", "event_id": "96695", "recalling_firm": "American Regent, Inc.", "address_1": "6610 New Albany Rd E", "address_2": "N/A", "postal_code": "43054-8730", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0398-2025", "product_description": "niCARdipine Hydrochloride Injection, USP, 25 mg/10 mL (2.5 mg/mL), 10 mL Single Dose Vial, Rx Only, Mfd for: Civica, Inc., Lehi, UT 84043,Mfd by: American Regent, Inc., New Albany, OH 43064. NDC Carton: 72572-470-10/ NDC Vial: 72572-470-01.", "product_quantity": "29,777 (cartons of 10 x 10mL vials)", "reason_for_recall": "Lack of sterility assurance: Product leakage around the vial neck, which could potentially result in a lack of sterility assurance.", "recall_initiation_date": "20250418", "center_classification_date": "20250501", "report_date": "20250507", "code_info": "Lots, expiry: Lot 24025N0C0, 6/30/2025; Lot 24115N0C0, 10/31/2025; Lot 24116N0C0, 3/31/2026; Lot 24160N0C0, 12/31/2025; Lot 24217N0C0, 01/31/2026; Lot 24288N0C0, 04/30/2026; Lot 24331N0C0, 5/31/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "East Brunswick", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA090778"], "brand_name": ["DULOXETINE"], "generic_name": ["DULOXETINE HYDROCHLORIDE"], "manufacturer_name": ["Rising Pharma Holdings, Inc."], "product_ndc": ["57237-017", "57237-018", "57237-019"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DULOXETINE HYDROCHLORIDE"], "rxcui": ["596926", "596930", "596934"], "spl_id": ["4166006e-ead3-4e01-8b11-07d26ac957ed"], "spl_set_id": ["ea2dc1a6-22d5-4295-9d39-9bf015dc5a89"], "package_ndc": ["57237-017-60", "57237-017-99", "57237-018-30", "57237-018-90", "57237-018-99", "57237-019-30", "57237-019-90", "57237-019-99"], "is_original_packager": [true], "upc": ["0357237018309", "0357237017609", "0357237019306"], "unii": ["9044SC542W"]}, "product_type": "Drugs", "event_id": "96074", "recalling_firm": "Rising Pharma Holding, Inc.", "address_1": "2 Tower Center Blvd Ste 1401", "address_2": "", "postal_code": "08816-1149", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0188-2025", "product_description": "Duloxetine Delayed-Release Capsules USP 30 mg, a) 30 count (NDC 57237-018-30) and b) 1000 count (NDC 57237-018-99) bottles, Rx only, Distributed by: Rising Pharm Holdings, Inc., East Brunswick, NJ", "product_quantity": "42,527 bottles", "reason_for_recall": "CGMP Deviations; Presence of N-nitroso-duloxetine impurity above recommended interim limit.", "recall_initiation_date": "20241230", "center_classification_date": "20250108", "report_date": "20250115", "code_info": "a) Lot# DT3023051A, exp. date Apr-25;  b) DT3023025A, exp. date Jan-25", "more_code_info": ""}, {"status": "Ongoing", "city": "Warren", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA205710"], "brand_name": ["BUDESONIDE"], "generic_name": ["BUDESONIDE"], "manufacturer_name": ["Cipla USA Inc."], "product_ndc": ["69097-318", "69097-319", "69097-321"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["BUDESONIDE"], "rxcui": ["252559", "349094", "351109"], "spl_id": ["664e2f07-caa9-41d7-9aa9-0b744c858de8"], "spl_set_id": ["c52c5382-1400-44b9-95be-a30e1cf706da"], "package_ndc": ["69097-318-86", "69097-318-87", "69097-318-32", "69097-318-53", "69097-319-86", "69097-319-87", "69097-319-32", "69097-319-53", "69097-321-86", "69097-321-87", "69097-321-32", "69097-321-53"], "is_original_packager": [true], "nui": ["N0000175576", "N0000175450"], "pharm_class_epc": ["Corticosteroid [EPC]"], "pharm_class_moa": ["Corticosteroid Hormone Receptor Agonists [MoA]"], "unii": ["Q3OKS62Q6X"]}, "product_type": "Drugs", "event_id": "97170", "recalling_firm": "Cipla USA, Inc.", "address_1": "10 Independence Blvd", "address_2": "N/A", "postal_code": "07059-2730", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0541-2025", "product_description": "Budesonide Inhalation Suspension, 0.5mg/2ml, 30 single-dose ampules per carton, five per pouch, RX Only, Manufactured by: Cipla Ltd. Indore SEZ, Pithampur, India. Manufactured for: Ciple USA, Inc. 10 Independence Boulevard, Suite 300, Warren, NJ 07059. NDC# 69097-319-86 (pouch), 69097-319-87 (carton)", "product_quantity": "13,680 ampoules", "reason_for_recall": "Lack of Assurance of Sterility: A market complaint was received for leakage and empty ampoule.", "recall_initiation_date": "20250630", "center_classification_date": "20250722", "report_date": "20250730", "code_info": "Batch # 4IA0505, Exp 09/31/2026"}, {"status": "Ongoing", "city": "Hawthorne", "state": "CA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "95994", "recalling_firm": "SHOPPERS- PLAZA", "address_1": "Fouad Panchibyaya 12816", "address_2": "", "postal_code": "90250", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide via internet sales", "recall_number": "D-0207-2025", "product_description": "FOUZEE SugarLin HERBAL FORMULA capsules, 180 capsules per bottle, Sold and Distributed by Shoppers-Plaza, Hawthorne, CA 90250. Product of India. UPC 8 26656 69047 7", "product_quantity": "172 180-count bottles", "reason_for_recall": "Marketed without an Approved NDA/ANDA; FDA laboratory analysis confirmed product tainted with undeclared metformin and glyburide", "recall_initiation_date": "20241216", "center_classification_date": "20250122", "report_date": "20250129", "code_info": "Batch # 001, exp. date 09/10/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Smyrna", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["505G(a)(3)"], "brand_name": ["HAND SANITIZER"], "generic_name": ["ETHYL ALCOHOL"], "manufacturer_name": ["Medline Industries, LP"], "product_ndc": ["53329-202"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["ALCOHOL"], "rxcui": ["581662"], "spl_id": ["42c83824-c26a-787f-e063-6394a90aedd7"], "spl_set_id": ["f84f7050-348d-4f75-ab93-e618ff8de790"], "package_ndc": ["53329-202-13", "53329-202-04", "53329-202-08", "53329-202-70", "53329-202-84", "53329-202-85", "53329-202-74"], "is_original_packager": [true], "upc": ["0193489179739", "888277349455"], "unii": ["3K9958V90M"]}, "product_type": "Drugs", "event_id": "96960", "recalling_firm": "Consumer Product Partners, LLC", "address_1": "1 Swan Dr", "address_2": "N/A", "postal_code": "37167-2099", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0458-2025", "product_description": "Spectrum Advanced Gel Hand Sanitizer, Ethyl alcohol 70%, 8 FL OZ (236 mL) per bottle, Manufactured for Medline Industries, Inc., Three Lakes Drive, Northfield, IL 60693 USA.  NDC:  53329-202-08, UPC 8 88277 34945 5", "product_quantity": "125,040 bottles", "reason_for_recall": "Subpotent product: Product has cloudy appearance and tested below assay label claim for 70% Ethyl Alcohol", "recall_initiation_date": "20250523", "center_classification_date": "20250605", "report_date": "20250611", "code_info": "Lot, expiry: Lot 0644682, exp 2026/11/14; Lot 0644683, exp 2026/11/16"}, {"status": "Ongoing", "city": "Allentown", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA019633"], "brand_name": ["STERILE WATER"], "generic_name": ["WATER"], "manufacturer_name": ["B. Braun Medical Inc."], "product_ndc": ["0264-7385"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["WATER"], "spl_id": ["ed933e44-2560-495b-879c-99c6a0bf8ba0"], "spl_set_id": ["8924e52e-8622-4ed6-a061-1908183e0a18"], "package_ndc": ["0264-7385-50", "0264-7385-60"], "is_original_packager": [true], "unii": ["059QF0KO0R"]}, "product_type": "Drugs", "event_id": "97477", "recalling_firm": "B BRAUN MEDICAL INC", "address_1": "861 Marcon Blvd", "address_2": "N/A", "postal_code": "18109-9577", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0652-2025", "product_description": "STERILE WATER FOR INJECTION USP, 3000mL, Rx only, B. Braun Medical Inc., Bethlehem. PA 18018, NDC 0264-7385-60.", "product_quantity": "26,316 3000 mL bags", "reason_for_recall": "Lack of Assurance of Sterility- Potential for fluid leakage from the port due to port misalignment.", "recall_initiation_date": "20250826", "center_classification_date": "20250916", "report_date": "20250924", "code_info": "Lot #:  J3L519, J3L528, Exp.: 31AUG2026 Lot #:  J4C522, J4C523, Exp.:28FEB2027"}, {"status": "Ongoing", "city": "Allentown", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA019632"], "brand_name": ["LACTATED RINGERS"], "generic_name": ["SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, AND CALCIUM CHLORIDE"], "manufacturer_name": ["B. Braun Medical Inc."], "product_ndc": ["0264-7750"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["CALCIUM CHLORIDE", "POTASSIUM CHLORIDE", "SODIUM CHLORIDE", "SODIUM LACTATE"], "rxcui": ["847630"], "spl_id": ["f67c6808-1eeb-4299-a0b7-694863bcad5a"], "spl_set_id": ["d3d29c8f-c326-4097-814a-7f4e08c67068"], "package_ndc": ["0264-7750-00", "0264-7750-10", "0264-7750-20"], "is_original_packager": [true], "unii": ["M4I0D6VV5M", "660YQ98I10", "451W47IQ8X", "TU7HW0W0QT"]}, "product_type": "Drugs", "event_id": "97368", "recalling_firm": "B BRAUN MEDICAL INC", "address_1": "861 Marcon Blvd", "address_2": "N/A", "postal_code": "18109-9577", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0585-2025", "product_description": "Lactated Ringer's Injection USP, L 7500, 1000mL Excel Container, Rx Only, Sterile, nonpyrogenic, single dose container, B. Braun Medical Inc., Bethlehem, PA 18018, NDC 0264-7750-00.", "product_quantity": "74,088 containers", "reason_for_recall": "Lack of Assurance of Sterility; potential for fluid leakage at one of the weld sites.", "recall_initiation_date": "20250804", "center_classification_date": "20250814", "report_date": "20250820", "code_info": "Lot #: J5C802, J5C917, J5C918, Exp. 08/31/2027", "more_code_info": ""}, {"status": "Ongoing", "city": "La Vergne", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA213368"], "brand_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "generic_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "manufacturer_name": ["Major Pharmaceuticals"], "product_ndc": ["0904-7129", "0904-7130", "0904-7131", "0904-7132", "0904-7133"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "rxcui": ["991039", "991044", "991188", "991194", "991336"], "spl_id": ["be5824c1-1eca-44db-a689-c67b9808c1f9"], "spl_set_id": ["d58570a0-58b0-4662-b2ad-aa8d1463b4c1"], "package_ndc": ["0904-7129-61", "0904-7130-61", "0904-7130-06", "0904-7131-61", "0904-7132-61", "0904-7133-61", "0030904713"], "original_packager_product_ndc": ["70710-1129", "70710-1130", "70710-1131", "70710-1132", "70710-1133"], "unii": ["9WP59609J6"]}, "product_type": "Drugs", "event_id": "97584", "recalling_firm": "The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories", "address_1": "341 Mason Rd", "address_2": "", "postal_code": "37086-3606", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0010-2026", "product_description": "Major ChlorproMAZINE Hydrochloride Tablets, USP, 25 mg, 100 Tablets (10x10) blister package, Rx Only, Packaged and Distributed by Major Pharmaceuticals, Indianapolis, IN 46268, USA, NDC 0904-7130-61, UPC (01)00309047130610", "product_quantity": "1256 blister packs", "reason_for_recall": "CGMP Deviations: Presence of N-Nitroso Desmethyl Chlorpromazine above the recommended intake limit", "recall_initiation_date": "20250912", "center_classification_date": "20251007", "report_date": "20251015", "code_info": "Lots N01954, Exp. Date, 11/30/2025 & N02024, Exp. Date, 02/28/2026", "more_code_info": ""}, {"status": "Terminated", "city": "Irving", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96600", "recalling_firm": "Medisca Inc.", "address_1": "6641 N Belt Line Rd Ste 130", "address_2": "N/A", "postal_code": "75063-6001", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "US Nationwide.", "recall_number": "D-0386-2025", "product_description": "Bimatoprost powder, Bulk Ingredient, a) 5g (NDC 38779-3066-03), b) 1g (NDC 38779-3066-06), c) 1g (NDC 38779-3066-09) drums, Medisca, Plattsburgh, NY", "product_quantity": "161.6 grams", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250331", "center_classification_date": "20250421", "termination_date": "20251010", "report_date": "20250430", "code_info": "Lot# 201727/A/B/C/D/E & F, exp.  date 05/31/2027, product # 3066 Lot# 208475/A/B/D/E/G/H & I, exp. date 09/30/2028, product # 3066"}, {"status": "Ongoing", "city": "Pennington", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA206745"], "brand_name": ["ENTECAVIR"], "generic_name": ["ENTECAVIR"], "manufacturer_name": ["Zydus Pharmaceuticals USA Inc."], "product_ndc": ["68382-920", "68382-921"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ENTECAVIR"], "rxcui": ["485434", "485436"], "spl_id": ["b9646f09-8d5b-4271-b2b1-b1d66a91ed73"], "spl_set_id": ["b4fd0e22-ad23-4f51-9b98-95182f63c2eb"], "package_ndc": ["68382-920-06", "68382-920-16", "68382-920-01", "68382-920-30", "68382-920-77", "68382-921-06", "68382-921-16", "68382-921-01", "68382-921-30", "68382-921-77"], "is_original_packager": [true], "unii": ["5968Y6H45M"]}, "product_type": "Drugs", "event_id": "97684", "recalling_firm": "Zydus Pharmaceuticals (USA) Inc", "address_1": "73 Route 31 N", "address_2": "N/A", "postal_code": "08534-3601", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0002-2026", "product_description": "Entecavir Tablets, USP, 1 mg, 30-count bottle, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 68382-921-06.", "product_quantity": "600 30-count bottles", "reason_for_recall": "Failed impurity/degradation specifications:Out of Specification result for an individual organic impurity", "recall_initiation_date": "20250924", "center_classification_date": "20251002", "report_date": "20251008", "code_info": "Lot#: E409309, Exp 12/31/2026"}, {"status": "Ongoing", "city": "North Bergen", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["M003"], "brand_name": ["DERMAKLEEN"], "generic_name": ["ANTIMICROBIAL DRUG PRODUCT"], "manufacturer_name": ["Dermarite Industries LLC"], "product_ndc": ["61924-092"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["CHLOROXYLENOL"], "rxcui": ["1549613", "1549618"], "spl_id": ["2889bd9a-c988-d5f3-e063-6394a90a19b9"], "spl_set_id": ["ff28985e-d941-4350-971f-fdc2dbbb93bb"], "package_ndc": ["61924-092-08", "61924-092-01", "61924-092-34", "61924-092-27", "61924-092-11"], "is_original_packager": [true], "upc": ["0714196098085"], "unii": ["0F32U78V2Q"]}, "product_type": "Drugs", "event_id": "97277", "recalling_firm": "DermaRite Industries, LLC", "address_1": "7777 W Side Ave", "address_2": "N/A", "postal_code": "07047-6436", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the USA", "recall_number": "D-0610-2025", "product_description": "DermaKleen, Health Care Antiseptic Lotion Soap with Vitamin E (Chloroxylenol 0.2%), packaged in a) 800 ml (27 fl. oz.) bag-n-box (NDC 61924-092-27)  and b) 1000ml (34 fl. oz.) bag-n-box (NDC 61924-092-34) , DermaRite Industries LLC, 7777 West Side Avenue, North Bergen, NJ 07047.", "product_quantity": "11,321 bag in boxes", "reason_for_recall": "Microbial Contamination of Non-Sterile Drug Product: The products were found to be contaminated with the bacteria Burkholderia cepecia.", "recall_initiation_date": "20250717", "center_classification_date": "20250902", "report_date": "20250910", "code_info": "Lot # and Expiration Date: a) 30550A, Exp. Date 7/2025; 30670A, 30682A, Exp. Date 8/2025; 40025A, Exp. Date 1/2026; 40375A, Exp. Date 4/2026; 40427A, 40436A, Exp. Date 5/2026; 50068A, Exp. Date 1/2027.  b)30586A, 30586B, 30626A, Exp. Date 7/2025; 30628A, 30657A, Exp. Date 8/2025;   30741A, Exp. Date 7/2025; 30871A, Exp. Date 10/2025; 40002A, Exp. Date 12/2025; 40012A, Exp. Date 1/2026; 40301A, Exp. Date 3/2026; 40789 A, Exp. Date 9/2026; 50068B, Exp. Date 1/2027; 50144A, 50149A, Exp. Date 2/2027."}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA078251"], "brand_name": ["CARVEDILOL"], "generic_name": ["CARVEDILOL"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-162", "68462-163", "68462-164", "68462-165"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CARVEDILOL"], "rxcui": ["200031", "200032", "200033", "686924"], "spl_id": ["5f5b2d20-cc2a-4e91-b2b9-260e7438ab2c"], "spl_set_id": ["c4a21f67-7812-4634-beba-f8e85c63c5f2"], "package_ndc": ["68462-162-60", "68462-162-01", "68462-162-18", "68462-162-05", "68462-162-10", "68462-163-60", "68462-163-01", "68462-163-18", "68462-163-05", "68462-163-10", "68462-164-60", "68462-164-01", "68462-164-18", "68462-164-05", "68462-164-10", "68462-165-60", "68462-165-01", "68462-165-18", "68462-165-05", "68462-165-10"], "is_original_packager": [true], "upc": ["0368462162019", "0368462163016", "0368462164013", "0368462165010"], "nui": ["N0000000099", "N0000009923", "N0000009924", "N0000175553", "N0000175556"], "pharm_class_moa": ["Adrenergic alpha-Antagonists [MoA]", "Adrenergic beta1-Antagonists [MoA]", "Adrenergic beta2-Antagonists [MoA]"], "pharm_class_epc": ["alpha-Adrenergic Blocker [EPC]", "beta-Adrenergic Blocker [EPC]"], "unii": ["0K47UL67F2"]}, "product_type": "Drugs", "event_id": "97372", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the USA", "recall_number": "D-0587-2025", "product_description": "Carvedilol Tablets, USP, 12.5 mg, 500 Tablets per carton, Rx Only, Manufactured by: Glenmark Pharmaceuticals Ltd., Plot No. 2, Phase-2, Pharma Zone SEZ, Pithampur, Dist.-Dhar, Madhya Pradesh 454 775, India.  Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 47430, NDC 68462-164-05", "product_quantity": "17, 496 bottles", "reason_for_recall": "CGMP Deviations: Results for N-Nitroso Carvedilol Impurity-1 (NNCI) impurity observed to be above the FDA-recommended limit of NMT 4.0 ppm", "recall_initiation_date": "20250806", "center_classification_date": "20250814", "report_date": "20250820", "code_info": "Lot #: 17241257, 17241258, 17241279, Exp. Date 06/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA077987"], "brand_name": ["PRAVASTATIN SODIUM"], "generic_name": ["PRAVASTATIN SODIUM"], "manufacturer_name": ["NorthStar RxLLC"], "product_ndc": ["16714-558", "16714-559", "16714-560", "16714-570"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["PRAVASTATIN SODIUM"], "rxcui": ["904458", "904467", "904475", "904481"], "spl_id": ["fa078b35-ee9d-4b9f-bb8d-e77949c09f88"], "spl_set_id": ["ce15ad07-3286-478f-9f30-1db6a45ed402"], "package_ndc": ["16714-558-01", "16714-558-02", "16714-559-01", "16714-559-02", "16714-560-01", "16714-560-02", "16714-570-01", "16714-570-02"], "is_original_packager": [true], "upc": ["0316714570013", "0316714559018", "0316714560014"], "unii": ["3M8608UQ61"]}, "product_type": "Drugs", "event_id": "96474", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0349-2025", "product_description": "Pravastatin Sodium Tablets, USP, 20mg, a).90-count bottle, Rx Only, Mfd for: Northstar Rx LLC, Memphis, TN 38141, Mfd by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India. NDC# 16714-559-01", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250313", "center_classification_date": "20250408", "report_date": "20250416", "code_info": "Lot #  17230810, exp. date Mar-26"}, {"status": "Ongoing", "city": "Unknown", "state": "N/A", "country": "China", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "96833", "recalling_firm": "EnShiShiXiangNiShangMaoYouXianGongSi", "address_1": "Unknown", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide Via Amazon Platform", "recall_number": "D-0453-2025", "product_description": "ENDURANCE BOOST WITH HORNY GOAT WEED, 500mg, 20 capsules per carton,  VEPEMVA Nutrition Supplement....rgy and Endurance, UPC X004BB9Z8N", "product_quantity": "600, 20-count cartons", "reason_for_recall": "Marketed without approved NDA/ANDA: The product has been found to be tainted with  Sildenafil and Propoxyphenylsildenafil (a sildenafil analogue).", "recall_initiation_date": "20250506", "center_classification_date": "20250529", "report_date": "20250604", "code_info": "Lot: 250214PRO, Expiration Date: 02/14/2027."}, {"status": "Ongoing", "city": "Pennington", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA213368"], "brand_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "generic_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "manufacturer_name": ["Northstar Rx LLC"], "product_ndc": ["16714-047", "16714-048", "16714-049", "16714-050", "16714-051"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "rxcui": ["991039", "991044", "991188", "991194", "991336"], "spl_id": ["13fe8f97-37e8-4d10-87fe-e1d17f4f23d8"], "spl_set_id": ["2bd42d3a-bf89-4d74-a252-9b914106a570"], "package_ndc": ["16714-047-01", "16714-048-01", "16714-049-01", "16714-050-01", "16714-051-01"], "is_original_packager": [true], "unii": ["9WP59609J6"]}, "product_type": "Drugs", "event_id": "97534", "recalling_firm": "Zydus Pharmaceuticals (USA) Inc", "address_1": "73 Route 31 N", "address_2": "N/A", "postal_code": "08534-3601", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0635-2025", "product_description": "Chlorpromazine Hydrochloride Tablets, USP, 50 mg, 100-count bottle, Rx only, Manufactured By: Zydus Lifesciences Ltd., Baddi, India; Manufactured for: Northstar Rx LLC Memphis, TN 38141.  NDC: 16714-049-01", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit", "recall_initiation_date": "20250903", "center_classification_date": "20250910", "report_date": "20250917", "code_info": "Lot #: Z306326, Exp Date 30-11-25; Z401155, Exp Date 28-02-26"}, {"status": "Ongoing", "city": "Alpharetta", "state": "GA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA210664"], "brand_name": ["DOXYCYCLINE"], "generic_name": ["DOXYCYCLINE HYCLATE"], "manufacturer_name": ["Acella Pharmaceuticals, LLC"], "product_ndc": ["42192-501"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DOXYCYCLINE HYCLATE"], "rxcui": ["1650143"], "spl_id": ["3b12eb84-4431-551b-e063-6294a90acd6c"], "spl_set_id": ["3fb9f5ad-90a2-4858-bc34-f800d8b2fa90"], "package_ndc": ["42192-501-50", "42192-501-05"], "is_original_packager": [true], "upc": ["0342192501058"], "unii": ["19XTS3T51U"]}, "product_type": "Drugs", "event_id": "97716", "recalling_firm": "Acella Pharmaceuticals, LLC", "address_1": "1880 Mcfarland Pkwy Ste 110", "address_2": "", "postal_code": "30005-1795", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0014-2026", "product_description": "Doxycycline Hyclate Tablets, USP 100 mg*, 500-count bottle, Rx Only, Distributed by: Acella Pharmaceuticals, LLC, Alpharetta, GA 30005, NDC 42192-501-05.", "product_quantity": "4,680 500-count bottles", "reason_for_recall": "Failed dissolution specifications: Stability testing found that the lot did not meet dissolution specifications.", "recall_initiation_date": "20250929", "center_classification_date": "20251009", "report_date": "20251015", "code_info": "Lot #: P24ZLK1, Exp 5/31/2027", "more_code_info": ""}, {"status": "Ongoing", "city": "Weston", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA078621"], "brand_name": ["AZELASTINE HYDROCHLORIDE"], "generic_name": ["AZELASTINE HYDROCHLORIDE"], "manufacturer_name": ["Apotex Corp."], "product_ndc": ["60505-0578"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAOCULAR"], "substance_name": ["AZELASTINE HYDROCHLORIDE"], "rxcui": ["860805"], "spl_id": ["6266ffd5-6ff5-dd31-01f3-a0ac961c826f"], "spl_set_id": ["77a33738-ffcf-221c-1562-780418882e5d"], "package_ndc": ["60505-0578-4"], "is_original_packager": [true], "unii": ["0L591QR10I"]}, "product_type": "Drugs", "event_id": "96954", "recalling_firm": "Apotex Corp.", "address_1": "2400 N Commerce Pkwy Ste 400", "address_2": "", "postal_code": "33326-3253", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "US Nationwide.", "recall_number": "D-0495-2025", "product_description": "Azelastine HCl Ophthalmic Solution, USP, 0.05%, 6 mL, Rx Only, Sterile, Mfg. by: Apotex Inc., Toronto, Ontario, Canada, M9L 1T9, Mfg. for: Apotex Corp., Weston, FL 33326, NDC 60505-0578-4", "product_quantity": "105,456 Bottles", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20250528", "center_classification_date": "20250625", "report_date": "20250702", "code_info": "Batch VD1654, Exp Date: 06/30/2027", "more_code_info": ""}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA078251"], "brand_name": ["CARVEDILOL"], "generic_name": ["CARVEDILOL"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-162", "68462-163", "68462-164", "68462-165"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CARVEDILOL"], "rxcui": ["200031", "200032", "200033", "686924"], "spl_id": ["5f5b2d20-cc2a-4e91-b2b9-260e7438ab2c"], "spl_set_id": ["c4a21f67-7812-4634-beba-f8e85c63c5f2"], "package_ndc": ["68462-162-60", "68462-162-01", "68462-162-18", "68462-162-05", "68462-162-10", "68462-163-60", "68462-163-01", "68462-163-18", "68462-163-05", "68462-163-10", "68462-164-60", "68462-164-01", "68462-164-18", "68462-164-05", "68462-164-10", "68462-165-60", "68462-165-01", "68462-165-18", "68462-165-05", "68462-165-10"], "is_original_packager": [true], "upc": ["0368462162019", "0368462163016", "0368462164013", "0368462165010"], "nui": ["N0000000099", "N0000009923", "N0000009924", "N0000175553", "N0000175556"], "pharm_class_moa": ["Adrenergic alpha-Antagonists [MoA]", "Adrenergic beta1-Antagonists [MoA]", "Adrenergic beta2-Antagonists [MoA]"], "pharm_class_epc": ["alpha-Adrenergic Blocker [EPC]", "beta-Adrenergic Blocker [EPC]"], "unii": ["0K47UL67F2"]}, "product_type": "Drugs", "event_id": "96474", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0336-2025", "product_description": "Carvedilol Tablets, USP 12.5 mg, 500-count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India, Manufactured for: Glenmark Pharmaceuticals Inc. USA, Mahwah, NJ 07430 NDC# 68462-164-05.", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250313", "center_classification_date": "20250408", "report_date": "20250416", "code_info": "Lot #  17240238, exp. date  Jan-26  17240243, exp. date  Jan-26 17240245, exp. date  Jan-26  17240248, exp. date  Jan-26"}, {"status": "Ongoing", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA074415"], "brand_name": ["SUCRALFATE"], "generic_name": ["SUCRALFATE"], "manufacturer_name": ["American Health Packaging"], "product_ndc": ["60687-695"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["SUCRALFATE"], "rxcui": ["314234"], "spl_id": ["37dbc9fb-25b5-30a2-e063-6294a90a78b8"], "spl_set_id": ["e7364686-3638-4061-ae4a-62b1df7af9d0"], "package_ndc": ["60687-695-11", "60687-695-01"], "original_packager_product_ndc": ["29033-003"], "nui": ["N0000175801", "M0015420"], "pharm_class_epc": ["Aluminum Complex [EPC]"], "pharm_class_cs": ["Organometallic Compounds [CS]"], "unii": ["XX73205DH5"]}, "product_type": "Drugs", "event_id": "97794", "recalling_firm": "Amerisource Health Services LLC", "address_1": "2550 John Glenn Ave Ste A", "address_2": "", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0027-2026", "product_description": "Sucralfate Tablets, USP 1 gram, 100 Tablets, (10x10), Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217, NDC 60687-695-01 - Carton NDC [60687-695-11- Unit Dose]", "product_quantity": "27,868 blister packs", "reason_for_recall": "CGMP Deviations: The recalling firm filed for Chapter 11 on September 30, 2024. As a result, it cannot monitor the quality program and hence cannot assure that products meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess, rendering the products adulterated.", "recall_initiation_date": "20251009", "center_classification_date": "20251016", "report_date": "20251022", "code_info": "Lot #: 1017392, Exp. Date 01/31/2026; 1017415, Exp. Date 12/31/2025.", "more_code_info": ""}, {"status": "Ongoing", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96996", "recalling_firm": "Tailstorm Health INC", "address_1": "24416 N 19th Ave Ste 200", "address_2": "", "postal_code": "85085-1400", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0501-2025", "product_description": "KETAmine Hydrochloride Injection, USP, 500mg/5mL, (10mg/mL), For IM or Slow IV Use, 5mL Sterile Multi-Dose Vial, Rx Only, For Office Use Only, Compounded Drug by: Medivant Healthcare, 158 S. Kyrene, Rd. Chandler, AZ 85226, NDC 81483-0007-2.", "product_quantity": "14,725 vials", "reason_for_recall": "Lack of Assurance of Sterility: A recent FDA inspection revealed concerns with the sterile manufacturing process.", "recall_initiation_date": "20250602", "center_classification_date": "20250630", "report_date": "20250709", "code_info": "Lot: 2502009, Exp. 3/2/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Flushing", "state": "NY", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "95980", "recalling_firm": "Buy-Herbal", "address_1": "13661 41st Ave", "address_2": "Box 239", "postal_code": "11355-2464", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "U.S Nationwide.", "recall_number": "D-0177-2025", "product_description": "Nhan Sam Tuyet Lien Truy Phong Hoan, Capsules, 30-Count Bottles, Manufactured by Yee Hong Pharmaceuticals, SDN, Penang, Malasia.", "product_quantity": "26 bottles", "reason_for_recall": "Marketed without an Approved NDA/ANDA: FDA analysis found the products to be tainted with undeclared Furosemide, Dexamethasone and Chlorpheniramine", "recall_initiation_date": "20241212", "center_classification_date": "20250103", "report_date": "20250115", "code_info": "All codes, unknown expiration dates all before 05/2030.", "more_code_info": ""}, {"status": "Ongoing", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA075576"], "brand_name": ["OMEPRAZOLE"], "generic_name": ["OMEPRAZOLE"], "manufacturer_name": ["Quallent Pharmaceuticals Health LLC"], "product_ndc": ["82009-022"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["OMEPRAZOLE"], "rxcui": ["198051"], "spl_id": ["61f30995-d9eb-8da3-661c-cd5cbf334f91"], "spl_set_id": ["665e9877-85ac-fdb6-54ac-1c47941ceab8"], "package_ndc": ["82009-022-10"], "is_original_packager": [true], "nui": ["N0000175525", "N0000000147", "N0000182140"], "pharm_class_epc": ["Proton Pump Inhibitor [EPC]"], "pharm_class_moa": ["Proton Pump Inhibitors [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]"], "unii": ["KG60484QX9"]}, "product_type": "Drugs", "event_id": "97161", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "107 College Rd E", "address_2": "N/A", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-0525-2025", "product_description": "Omeprazole Delayed-release Capsules, USP, 20mg, 1000-count bottle, Rx Only, Manufactured by: Dr. Reddy's Laboratories Limited, Bachupally - 500 090 INDIA, Manufactured for: Qualient Pharmaceuticals Health LLC, Grand Cayman, Cayman Islands, NDC 82009-022-10.  NDC 82009-022-10", "product_quantity": "1476 bottles", "reason_for_recall": "Presence of foreign tablets/capsules: presence of foreign Divalproex Sodium Extended-Release 250mg tablet in a bottle of omeprazole capsules.", "recall_initiation_date": "20250630", "center_classification_date": "20250714", "report_date": "20250723", "code_info": "Lot: C2403017, Exp 12/31/2026"}, {"status": "Ongoing", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA090858"], "brand_name": ["GABAPENTIN"], "generic_name": ["GABAPENTIN"], "manufacturer_name": ["Major Pharmaceuticals"], "product_ndc": ["0904-6665", "0904-6666", "0904-6667"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["GABAPENTIN"], "rxcui": ["310430", "310431", "310432"], "spl_id": ["b6880b32-3ebc-4b0e-8a84-d513f3e401af"], "spl_set_id": ["36f74fdf-0dae-47a0-a7ea-e64ac91cd88f"], "package_ndc": ["0904-6665-61", "0904-6666-61", "0904-6667-61"], "original_packager_product_ndc": ["67877-222", "67877-223", "67877-224"], "nui": ["N0000008486"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "unii": ["6CW7F3G59X"]}, "product_type": "Drugs", "event_id": "97087", "recalling_firm": "The Harvard Drug Group LLC", "address_1": "7000 Cardinal Pl", "address_2": "", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0507-2025", "product_description": "Gabapentin Capsules, USP, 100 mg, 100 capsules (10x10), blister pack cartons, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN, 46268 USA, NDC 0904-6665-61", "product_quantity": "23,232 cartons", "reason_for_recall": "Defective container; blister packaging inadequately sealed.", "recall_initiation_date": "20250619", "center_classification_date": "20250703", "report_date": "20250709", "code_info": "Lot# M05205, Exp Date 10/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA209101"], "brand_name": ["HALOPERIDOL DECANOATE"], "generic_name": ["HALOPERIDOL DECANOATE"], "manufacturer_name": ["BluePoint Laboratories"], "product_ndc": ["68001-578", "68001-579", "68001-580", "68001-581", "68001-582"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR"], "substance_name": ["HALOPERIDOL DECANOATE"], "rxcui": ["859871", "1719803", "1719862"], "spl_id": ["048557ea-f859-f0f2-e063-6294a90af5ab"], "spl_set_id": ["f2d14406-2ad4-4c5b-9c24-a026f27b415d"], "package_ndc": ["68001-579-59", "68001-579-48", "68001-580-41", "68001-581-41", "68001-581-48", "68001-581-82", "68001-578-59", "68001-578-48", "68001-582-41"], "is_original_packager": [true], "upc": ["0368001578592", "0368001581417", "0368001579599", "0368001582414"], "unii": ["AC20PJ4101"]}, "product_type": "Drugs", "event_id": "96636", "recalling_firm": "Amerisource Health Services LLC", "address_1": "2550 John Glenn Ave Ste A", "address_2": "N/A", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0369-2025", "product_description": "Haloperidol Decanoate Injection, 100mg/mL*, 5 x 1 mL Single-Dose Vials, Rx Only,  Manufactured by: Somerset Therapeutics Limited, #54/1 Boodhihal Village, Nelamangala, Bangalore -562123, Karnataka, India, Manufactured for: BluePoint Laboratories, NDC 68001-581-48.", "product_quantity": "143 1x5 vials", "reason_for_recall": "Lack of assurance of sterility. Bacterial contamination detected in some media fill units", "recall_initiation_date": "20250402", "center_classification_date": "20250418", "report_date": "20250430", "code_info": "A240482B, EXP 08/31/2026"}, {"status": "Ongoing", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["BLA125294"], "brand_name": ["GRANIX"], "generic_name": ["TBO-FILGRASTIM"], "manufacturer_name": ["Cephalon, LLC"], "product_ndc": ["63459-910", "63459-912", "63459-918", "63459-920"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["SUBCUTANEOUS"], "substance_name": ["FILGRASTIM"], "rxcui": ["1433768", "1433771", "1442681", "1442683", "2101456", "2101459", "2101464", "2101465"], "spl_id": ["063f36a7-6f99-40fa-af02-8a5183c51e99"], "spl_set_id": ["df918ec2-0907-443f-a52a-b72866959644"], "package_ndc": ["63459-910-01", "63459-910-12", "63459-910-11", "63459-910-15", "63459-910-18", "63459-910-17", "63459-910-36", "63459-912-01", "63459-912-12", "63459-912-11", "63459-912-15", "63459-912-18", "63459-912-17", "63459-912-36", "63459-918-53", "63459-918-59", "63459-920-53", "63459-920-59"], "is_original_packager": [true], "nui": ["M0024696", "N0000009451", "N0000175666"], "pharm_class_cs": ["Granulocyte Colony-Stimulating Factor [CS]"], "pharm_class_pe": ["Increased Myeloid Cell Production [PE]"], "pharm_class_epc": ["Leukocyte Growth Factor [EPC]"], "unii": ["PVI5M0M1GW"]}, "product_type": "Drugs", "event_id": "96115", "recalling_firm": "Teva Pharmaceuticals USA, Inc", "address_1": "400 Interpace Pkwy Bldg A", "address_2": "", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed nationwide.", "recall_number": "D-0218-2025", "product_description": "Granix (tbo-filgrastim) Injection 300 mcg/0.5 mL, Single Dose prefilled syringe, packaged as a) 1 syringe in 1 CARTON, NDC 63459-910-11, Blister NDC 63459-910-12; (b)10 syringes in 1 CARTON, NDC 63459-910-15, Blister NDC 63459-910-12; (c) 1 syringe in 1 CARTON, NDC 63459-910-17 without safety guard and blister, Rx Only, Manufactured by: UAB Teva Baltics, Vilnius, Lithuania. Distributed by Teva Pharmaceuticals USA, Inc. North Wales PA 19454. Product of Israel.", "product_quantity": "34,636 cartons", "reason_for_recall": "Failed Stability Specifications - 12-month stability test result for one of the known peptides is below the specification limit", "recall_initiation_date": "20250110", "center_classification_date": "20250204", "report_date": "20250212", "code_info": "Lot #  (a) 135738, (b) 137149, (c) 137148, Exp. date 09/30/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "East Windsor", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA216379"], "brand_name": ["TIROFIBAN"], "generic_name": ["TIROFIBAN"], "manufacturer_name": ["Eugia US LLC"], "product_ndc": ["55150-429", "55150-430"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["TIROFIBAN HYDROCHLORIDE"], "rxcui": ["1737466", "1737471"], "spl_id": ["1751523a-e22e-4faf-bdb1-c850afe2fd36"], "spl_set_id": ["d554acff-22e9-4f28-b826-ee1b91daa2df"], "package_ndc": ["55150-429-01", "55150-430-01"], "is_original_packager": [true], "upc": ["0355150430017", "0355150429011"], "unii": ["6H925F8O5J"]}, "product_type": "Drugs", "event_id": "96718", "recalling_firm": "Eugia US LLC", "address_1": "279 Princeton Hightstown Rd", "address_2": "N/A", "postal_code": "08520-1401", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-0389-2025", "product_description": "Tirofiban Hydrochloride Injection 5 mg/100 mL (50 mcg/mL), 100 mL single-dose container (bag), Rx only, Manufactured in India for: Eugia U.S. LLC, 279 Princeton-Hightstown Rd., E. Windsor, NJ 08520, NDC 55150-429-01", "product_quantity": "18,867 bags", "reason_for_recall": "Out-of-Specification test results were obtained in at long term conditions during 3 month's stability study for related substances.", "recall_initiation_date": "20250421", "center_classification_date": "20250425", "report_date": "20250507", "code_info": "Lot #: 3TF24002A, Exp 11/30/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Clark", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96390", "recalling_firm": "L'Oreal USA", "address_1": "222 Terminal Ave", "address_2": "", "postal_code": "07066-1317", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0419-2025", "product_description": "La Roche-Posay Laboratoire Dermatologique Effaclar Duo Dual Action Acne Treatment, 5.5% Benzoyl Peroxide Acne Medication, a) UPC 3606000508804, 20 mL (0.7 fl. oz.) Tube per Carton, b) 883140500759, 40 mL (1.35 fl. oz.) Tube per Carton, La Roche-Posay LLC, 10 Hudson Yards, New York, NY 10001, La Roche-Posay, France.", "product_quantity": "", "reason_for_recall": "cGMP Deviations: The recall was initiated due to detected trace levels of benzene in a specific lot of this product lot (MYX46W), however out of an abundance of caution, the firm voluntarily recalled all La Roche-Posay Effaclar Duo Dual Action Acne Treatment lots.", "recall_initiation_date": "20250305", "center_classification_date": "20250509", "report_date": "20250521", "code_info": "a) Lot #s, Expiration dates: MYX30W 03/2025 MYX43W 04/2025 MYX41W 04/2025 MYX42W 04/2025 MYX40W 04/2025 MYX51W 05/2025 MYX50W 05/2025 MYX60W 05/2025 MYX71W 06/2025 MYX90W 08/2025 MYX91W 09/2025 MYX92W 08/2025 MYXO0W 09/2025 MYX93W  09/2025 MYXD1W  11/2025 MYXD2W  11/2025 MYXDOW 09/2025 MYXD4W  11/2025 MYXD3W  11/2025 MYY22W  02/2026 MYY21W  02/2026 MYY20W  02/2026 MYY41W  04/2026 MYY40W  04/2026 MYY42W  04/2026 MYY43W  04/2026 MYY52W  05/2026 MYY51W  05/2026 MYY50W  05/2026 MYY60W  06/2026  b) Lot #s, Expiration dates MYX31W  3/2025  MYX32W  3/2025  MYX33W  3/2025  MYX34W  3/2025  MYX35W  3/2025  MYX40W  3/2025  MYX41W  4/2025  MYX42W  4/2025  MYX44W  4/2025  MYX45W  4/2025   MYX47W  4/2025  MYX48W  4/2025  MYX49W  4/2025  MYX50W  5/2025  MYX51W  5/2025  MYX52W  5/2025  MYX70W  6/2025  MYX71W  6/2025  MYX72W  7/2025  MYX73W  7/2025  MYX74W  7/2025  MYX75W  7/2025  MYX77W  7/2025  MYX78W  7/2025  MYX80W  8/2025  MYX81W  7/2025  MYX82W  8/2025  MYX83W  8/2025  MYX84W  7/2025  MYXO0W  9/2025  MYXO1W  8/2025  MYXO3W  8/2025  MYXO4W  9/2025  MYXO5W  9/2025  MYXO7W  9/2025  MYXO8W  8/2025  MYXO9W  9/2025  MYXD0W  11/2025  MYXD1W  12/2025  MYXD2W  11/2025  MYXD3W  11/2025  MYXD4W  11/2025  MYXD5W  11/2025  MYXD6W  12/2025  MYY22W  02/2026  MYY23W  02/2026  MYY30W  02/2026  MYY31W  03/2026  MYY32W  03/2026  MYY40W  03/2026  MYY41W  04/2026  MYY42W  04/2026  MYY43W  04/2026  MYY51W  04/2026  MYY60W  06/2026  MYY61W  06/2026  MYY62W  06/2026  MYY63W  06/2026  MYY64W    06/2026 MYY65W    06/2026 MYY66W    06/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Chambersburg", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "97688", "recalling_firm": "Acuity Specialty Products, Inc.", "address_1": "800 Development Ave", "address_2": "", "postal_code": "17201-4103", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "US Nationwide.", "recall_number": "D-0005-2026", "product_description": "AFCO, Hand Sanitizer (Isopropyl Alcohol-Based, Product 5515), Manufactured by: AFCO, 550 Development Avenue, Chambersburg, PA 17201, Toll Free: 800-345-1329, Package Configuration: a) 4x1 Gallon Case, 5 Gallon Pail, 55 Gallon Drum.", "product_quantity": "", "reason_for_recall": "cGMP deviations: The recall was initiated because required receipt testing of incoming alcohol components used to manufacture the listed hand sanitizers was not performed, so methanol risk could not be excluded.", "recall_initiation_date": "20250929", "center_classification_date": "20251006", "report_date": "20251015", "code_info": "Lot # C2432725, Exp 11/22/2025; Lot # C2508304, Exp 3/24/2026; Lot # C2509304, Exp 4/3/2026.", "more_code_info": ""}, {"status": "Ongoing", "city": "Easton", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M019"], "brand_name": ["POWER STICK FOR HER ROLL- ON ANTIPERSPIRANT DEODORANT POWDER FRESH"], "generic_name": ["ALUMINUM SESQUICHLOROHYDRATE"], "manufacturer_name": ["A.P. Deauville, LLC"], "product_ndc": ["42913-038"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["ALUMINUM SESQUICHLOROHYDRATE"], "spl_id": ["1d47ead6-1fba-cabc-e063-6294a90aa50f"], "spl_set_id": ["00419359-e53a-46a6-8be5-401e4c72060e"], "package_ndc": ["42913-038-00", "8151950193"], "is_original_packager": [true], "upc": ["0815195019313", "815195019313"], "unii": ["UCN889409V"]}, "product_type": "Drugs", "event_id": "97211", "recalling_firm": "A.P. Deauville, LLC", "address_1": "3700 Glover Rd", "address_2": "N/A", "postal_code": "18040-9285", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0548-2025", "product_description": "Power Stick for her PH Balanced Roll-On Antiperspirant Deodorant with Powder Fresh Scent, 1.8 oz./53 mL, A.P Deauville, LLC, PA 18040, NDC# 42913-038-00, UPC Code 815195019313", "product_quantity": "21,265 cases", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250710", "center_classification_date": "20250731", "report_date": "20250723", "code_info": "Lot #  032026B011, 032226B031, 051626C241, 061526C882, 071226D371, 071226D381, 082526E341, 082826E402"}, {"status": "Ongoing", "city": "Melville", "state": "NY", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "96290", "recalling_firm": "Ascent Consumer Products Inc.", "address_1": "105 Baylis Rd", "address_2": "N/A", "postal_code": "11747-3833", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the US.", "recall_number": "D-0301-2025", "product_description": "SinuCleanse Soft Tip NETI POT Nasal Wash System (sodium bicarbonate USP 700 mg and sodium chloride USP 2300 mg), 30-count All Natural USP Grade Saline Packets and 1 kettle style Neti Pot, Net WT 0.1OZ (3g) each, Distributed by Ascent Consumer Products Inc., Melville, NY 11747, UPC 6 46011 00102 7", "product_quantity": "unknown", "reason_for_recall": "Microbial Contamination of Non-Sterile Products: Bacterial contamination with Staphylococcus aureus", "recall_initiation_date": "20250128", "center_classification_date": "20250325", "report_date": "20250402", "code_info": "Lot# 024122661Al, Exp Date 12/2027"}, {"status": "Ongoing", "city": "Racine", "state": "WI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96324", "recalling_firm": "Johnson, S C and Son, Inc", "address_1": "1525 Howe St", "address_2": "", "postal_code": "53403-2237", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "", "distribution_pattern": "Nationwide within the United States and Canada", "recall_number": "D-0276-2025", "product_description": "Kids by babyganics SPF 50 mineral sunscreen totally tropical (titanium dioxide 3/5%, zinc oxide 7.25%), packaged in 3 OZ spray bottles, Dist. by KAS Direct LLC, 1525 Howe St. Racine, WI 53403, UPC 813277019923 and UPC 813277019916", "product_quantity": "493,462 units", "reason_for_recall": "Chemical Contamination", "recall_initiation_date": "20250213", "center_classification_date": "20250312", "report_date": "20250319", "code_info": "UPC 813277019916  Lot #: A033 / 5880343A, A054 / 2030633A, A058 / 2050633A, A058 / 2050633B, A058 / 2060633A, A058 / 2070633A, A058 / 2040633A, A059 / 2080633A, Exp. Date Feb-25;  A314 / 4513223A, Exp. Date Nov-25; C054 / 2090774A, C057 / 2100774A, Exp. Date Feb-26; C131 / 3201394A, C131 / 3211394A, C131 / 3211394B, C131 / 3211394C, Exp. Date May-26  UPC 813277019923  Lot #: A060 / 3780693A, A060 / 3780693B, Exp. Date Mar-25; C067 / 2110774A, C067 / 2110774B, C067 / 2110774C, Exp. Date Mar-26; C169 / 7921734A, C169 / 7921734B, Exp. Date Jun-26", "more_code_info": ""}, {"status": "Ongoing", "city": "Torrance", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96699", "recalling_firm": "Nubratori, Inc", "address_1": "381 Van Ness Ave Ste 1507", "address_2": "N/A", "postal_code": "90501-7220", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "PA and CA.", "recall_number": "D-0392-2025", "product_description": "Dexonto 0.4% (dexamethasone sodium phosphate) solution 20 mg/5 mL (4 mg/mL), Rx Only, 12 - 5 mL Single Dose Units per box, Preservative Free, For Iontophoresis Use Only, Non-Sterile Product, Not for Injection, NUBRATORI RX, 381 Van Ness Ave# 1507, CA 90501, NDC 71300-6564-1 (box), 71300-6564-3 (vial).", "product_quantity": "20 boxes", "reason_for_recall": "Labeling: Incorrect or Missing Lot and/or Expiration date: Individual vials of Dexonto 0.4%, are labeled correctly with the BUD of 12/25/2024, however, the outer box on some of the Dexonto 0.4% are labeled incorrectly with a BUD of 12/25/2025.", "recall_initiation_date": "20250415", "center_classification_date": "20250428", "report_date": "20250507", "code_info": "Lot #: C04292401X1, BUD: 12/25/2025 (box).", "more_code_info": ""}, {"status": "Ongoing", "city": "Berkeley Heights", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA203088"], "brand_name": ["DULOXETINE"], "generic_name": ["DULOXETINE HYDROCHLORIDE"], "manufacturer_name": ["Breckenridge Pharmaceutical, Inc."], "product_ndc": ["51991-746", "51991-747", "51991-748", "51991-750"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DULOXETINE HYDROCHLORIDE"], "rxcui": ["596926", "596930", "596934", "616402"], "spl_id": ["32327581-bdab-41ac-9adc-bf208e1c4e42"], "spl_set_id": ["caef6f50-1571-4ec7-8f8c-42b924d323ee"], "package_ndc": ["51991-746-06", "51991-746-90", "51991-746-05", "51991-747-33", "51991-747-90", "51991-747-10", "51991-748-33", "51991-748-90", "51991-748-10", "51991-750-33", "51991-750-90", "51991-750-05", "51991-750-10"], "is_original_packager": [true], "unii": ["9044SC542W"]}, "product_type": "Drugs", "event_id": "97179", "recalling_firm": "Breckenridge Pharmaceutical, Inc.", "address_1": "200 Connell Dr Ste 4200", "address_2": "N/A", "postal_code": "07922-2805", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0511-2025", "product_description": "Duloxetine Delayed-Release Capsules, USP, 40mg, 30-count bottles, Rx Only,   Mfr. by: Towa Pharmaceutical Europe, S.L. Martorelles, (Barcelona), Spain, Dist. by: Breckenridge Pharmaceuticals, Inc., Berkeley Heights, NJ 07922. NDC 51991-750-33.", "product_quantity": "12,242 30-count bottles", "reason_for_recall": "CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit", "recall_initiation_date": "20250630", "center_classification_date": "20250709", "report_date": "20250716", "code_info": "Lot # 230199, Exp. Date 01/31/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Malvern", "state": "PA", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["ANDA077171"], "brand_name": ["CLONAZEPAM"], "generic_name": ["CLONAZEPAM"], "manufacturer_name": ["Par Health USA, LLC"], "product_ndc": ["49884-306", "49884-307", "49884-308", "49884-309", "49884-310"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CLONAZEPAM"], "rxcui": ["349194", "349195", "349196", "349197", "349198"], "spl_id": ["8b72ac75-deb8-4acf-b411-9dd5d13dd51c"], "spl_set_id": ["1aef0069-80ea-483d-ac70-c8d485462c5b"], "package_ndc": ["49884-306-02", "49884-307-02", "49884-308-02", "49884-309-02", "49884-310-02", "49884-309-52"], "is_original_packager": [true], "upc": ["0349884308025"], "nui": ["N0000175694", "M0002356"], "pharm_class_epc": ["Benzodiazepine [EPC]"], "pharm_class_cs": ["Benzodiazepines [CS]"], "unii": ["5PE9FDE8GB"]}, "product_type": "Drugs", "event_id": "95778", "recalling_firm": "Endo USA, Inc.", "address_1": "1400 Atwater Dr", "address_2": "", "postal_code": "19355-8701", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0181-2025", "product_description": "Clonazepam Orally Disintegrating Tablets, USP, 1 mg, C-IV, Rx Only, 60 tablets per carton (10 blister cards containing 6 tablets each), Distributed by: PAR Pharmaceutical, Chestnut Ridge, NY 10977, NDC#: 49884-309-02 (carton), NDC #: 49884-309-52 (blisters).", "product_quantity": "22,513 cartons", "reason_for_recall": "Labeling: Label Error on Declared Strength; Some cartons were incorrectly labeled. The blister strips inside the product carton reflect the correct strength.", "recall_initiation_date": "20241118", "center_classification_date": "20250103", "report_date": "20250115", "code_info": "Lot #s: 550145201, Exp. 08/31/2026; 550175901, 550176001, 550176201, Exp. 02/28/2027", "more_code_info": ""}, {"status": "Ongoing", "city": "Aurangabad, Maharashtra State", "state": "", "country": "India", "classification": "Class II", "openfda": {"application_number": ["ANDA077259"], "brand_name": ["TIMOLOL MALEATE"], "generic_name": ["TIMOLOL MALEATE"], "manufacturer_name": ["Rising Pharma Holdings, Inc."], "product_ndc": ["64980-513", "64980-514"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["TIMOLOL MALEATE"], "rxcui": ["1923428", "1992303"], "spl_id": ["7ef88352-6fe4-48a4-b72b-15419d3ed051"], "spl_set_id": ["2ed21930-1e05-46de-8acd-cb6f4798a7fa"], "package_ndc": ["64980-513-05", "64980-513-01", "64980-513-15", "64980-514-05", "64980-514-01", "64980-514-15"], "is_original_packager": [true], "upc": ["0364980513050", "0364980514057"], "unii": ["P8Y54F701R"]}, "product_type": "Drugs", "event_id": "97219", "recalling_firm": "FDC Limited", "address_1": "B-8 MIDC Industrial Area", "address_2": "Waluj District", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S Nationwide.", "recall_number": "D-0543-2025", "product_description": "Timolol Maleate Ophthalmic Solution USP, 0.5%, Sterile, 5mL bottles, Rx only, Manufactured by: FDC Limited, Waluj, Aurangabad, Maharashtra, India, Distributed by: Rising Pharmaceuticals Inc, New Jersey, NDC 64980-514-05.", "product_quantity": "154,176 bottles", "reason_for_recall": "Defective Container: spike of the cap becomes lodged in the nozzle of the product bottle.", "recall_initiation_date": "20250705", "center_classification_date": "20250729", "report_date": "20250806", "code_info": "Lot#: 083L061, Exp.: 11/2025.", "more_code_info": ""}, {"status": "Ongoing", "city": "Saint Louis", "state": "MO", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M018"], "brand_name": ["CARBOXYMETHYLCELLULOSE SODIUM"], "generic_name": ["CARBOXYMETHYLCELLULOSE SODIUM"], "manufacturer_name": ["AvPAK"], "product_ndc": ["50268-066"], "product_type": ["HUMAN OTC DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["CARBOXYMETHYLCELLULOSE SODIUM"], "rxcui": ["579907"], "spl_id": ["130364f2-4379-9324-e063-6294a90a9747"], "spl_set_id": ["b469f1c4-bd94-6f50-e053-2995a90a452f"], "package_ndc": ["50268-066-15"], "is_original_packager": [true], "unii": ["K679OBS311"]}, "product_type": "Drugs", "event_id": "96741", "recalling_firm": "BRS Analytical Services, LLC", "address_1": "11697 Lakeside Crossing Ct", "address_2": "N/A", "postal_code": "63146-8606", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0405-2025", "product_description": "Carboxymethylcellulose Sodium Ophthalmic Gel 1%, Carboxymethlycellulose Sodium 1% Eye Lubricant, Lubricant Eye Gel, Soothing Gel, Sterile, 0.5 FL OZ (15mL) per bottle, Distributed by: AvKARE, Pulaski, TN 38478, NDC: 50268-066-15.", "product_quantity": "1,610 cases (24 cartons per case)", "reason_for_recall": "cGMP deviations and lack of assurance of sterility.", "recall_initiation_date": "20250423", "center_classification_date": "20250506", "report_date": "20250514", "code_info": "Lot, expiry:  Lot 114, exp 9/04/25; Lot 115, exp 9/06/25; Lot 116, exp 9/10/25; Lot 207, exp 12/05/26", "more_code_info": ""}, {"status": "Ongoing", "city": "Bedminster", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA209042"], "brand_name": ["AMLODIPINE AND OLMESARTAN MEDOXOMIL"], "generic_name": ["AMLODIPINE AND OLMESARTAN MEDOXOMIL"], "manufacturer_name": ["Ascend Laboratories, LLC"], "product_ndc": ["67877-499", "67877-500", "67877-501", "67877-502"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["AMLODIPINE BESYLATE", "OLMESARTAN MEDOXOMIL"], "rxcui": ["730861", "730866", "730869", "730872"], "spl_id": ["32238052-6c4c-4b29-a59e-524c819c69f1"], "spl_set_id": ["c1204fbe-d086-43cf-bbaa-efec9cd0487c"], "package_ndc": ["67877-499-30", "67877-499-90", "67877-500-30", "67877-500-90", "67877-501-30", "67877-501-90", "67877-502-30", "67877-502-90"], "is_original_packager": [true], "unii": ["6M97XTV3HD", "864V2Q084H"]}, "product_type": "Drugs", "event_id": "97293", "recalling_firm": "Ascend Laboratories, LLC", "address_1": "135 Us Highway 202 206 Ste 15", "address_2": "N/A", "postal_code": "07921-2608", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0576-2025", "product_description": "Amlodipine and Olmesartan Medoxomil Tablets, 5 mg/ 40 mg, 30-count bottle, Rx Only, Manufactured by: Alkem Laboratories Ltd., INDIA; Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054, NDC 67877-501-30", "product_quantity": "8,568 bottles", "reason_for_recall": "Failed Dissolution Specifications: low dissolution results", "recall_initiation_date": "20250721", "center_classification_date": "20250808", "report_date": "20250820", "code_info": "Lot 23121560, Exp 4/30/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "97360", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide Within the U.S.", "recall_number": "D-0573-2025", "product_description": "RECOMBINATE, [Antihemophilic Factor (Recombinant)], 5 mL vials, Rx Only, Takeda Pharmaceuticals USA, Cambridge, MA 02142, NDC: 00944-2843-01", "product_quantity": "3 units", "reason_for_recall": "CGMP Deviations - Product was exposed to temperatures outside the product's labeled storage requirements.", "recall_initiation_date": "20250730", "center_classification_date": "20250807", "report_date": "20250813", "code_info": "Lot: TRB23802AC, Expires: 03/18/2026; TRA22804AA, Expires: 10/18/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Bridgewater", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA076899"], "brand_name": ["SULFAMETHOXAZOLE AND TRIMETHOPRIM"], "generic_name": ["SULFAMETHOXAZOLE AND TRIMETHOPRIM"], "manufacturer_name": ["Amneal Pharmaceuticals LLC"], "product_ndc": ["65162-271", "65162-272"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["SULFAMETHOXAZOLE", "TRIMETHOPRIM"], "rxcui": ["198334", "198335"], "spl_id": ["6cbe0ea0-5ed0-4941-ad3c-4396a56fdfc6"], "spl_set_id": ["f0e73842-6002-43c2-97fc-0cadc1bf6346"], "package_ndc": ["65162-271-05", "65162-271-10", "65162-271-50", "65162-271-11", "65162-272-01", "65162-272-24", "65162-272-10", "65162-272-25", "65162-272-50"], "is_original_packager": [true], "upc": ["0365162271102", "0365162272109"], "nui": ["N0000175504", "M0020790", "N0000185504", "N0000175489", "N0000000191", "N0000187062", "N0000187061"], "pharm_class_epc": ["Sulfonamide Antimicrobial [EPC]", "Dihydrofolate Reductase Inhibitor Antibacterial [EPC]"], "pharm_class_cs": ["Sulfonamides [CS]"], "pharm_class_moa": ["Cytochrome P450 2C9 Inhibitors [MoA]", "Dihydrofolate Reductase Inhibitors [MoA]", "Cytochrome P450 2C8 Inhibitors [MoA]", "Organic Cation Transporter 2 Inhibitors [MoA]"], "unii": ["JE42381TNV", "AN164J8Y0X"]}, "product_type": "Drugs", "event_id": "97438", "recalling_firm": "Amneal Pharmaceuticals, LLC", "address_1": "400 Crossing Blvd Fl 3", "address_2": "N/A", "postal_code": "08807-2863", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0615-2025", "product_description": "Sulfamethoxazole and Trimethoprim Tablets, USP 800mg/160mg, Double Strength, Rx Only, Packaged as a) 100-count bottle, NDC 65162-272-10; b) 500-count bottle, NDC  65162-272-50; Manufactured by: Amneal Pharmaceuticals, Pvt. Ltd, Oral Solid Dosage Unit, Ahmedabad, 382213, INDIA, Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807.", "product_quantity": "60,072 100-count, 73,054 500-count bottles", "reason_for_recall": "Presence of a foreign substance.A specific lot of auxiliary polyester coil, used in product packaging was   detected with presence of a micro-organism. No micro-organism was detected on any tablets.", "recall_initiation_date": "20250818", "center_classification_date": "20250904", "report_date": "20250910", "code_info": "Lot a) AM240173, Exp Date 01/31/2027, AM240680, Exp Date 05/31/2027, AM 240921, Exp Date 06/30/2027, AM241191, Exp Date 08/31/2027.  Lot b) AM240176, AM240177, Exp Date 01/31/2027, AM240301, AM240300, Exp Date 02/28/2027, AM240676, AM240677, Exp Date 04/30/2027, AM240678, AM240679, Exp Date 05/30/2027. AM240922, AM240923, AM240924, AM240925, Exp Date 6/30/27, AM241086, Exp Date 7/31/27, AM241087, AM241088, Exp Date 8/31/27."}, {"status": "Ongoing", "city": "North Bergen", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["M003"], "brand_name": ["KLEENFOAM"], "generic_name": ["OTC ANTIMICROBIAL DRUG PRODUCT"], "manufacturer_name": ["Dermarite Industries LLC"], "product_ndc": ["61924-093"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["CHLOROXYLENOL"], "rxcui": ["1550947"], "spl_id": ["288a1f32-8469-3958-e063-6394a90ae41a"], "spl_set_id": ["f4ea9ae8-c783-48b4-af31-a26ecaa34992"], "package_ndc": ["61924-093-34"], "is_original_packager": [true], "upc": ["0714196093349"], "unii": ["0F32U78V2Q"]}, "product_type": "Drugs", "event_id": "97277", "recalling_firm": "DermaRite Industries, LLC", "address_1": "7777 W Side Ave", "address_2": "N/A", "postal_code": "07047-6436", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the USA", "recall_number": "D-0612-2025", "product_description": "KleenFoam, Antimicrobial Foam Soap with Aloe Vera, (Chloroxylenol 0.5%) 34 FL OZ (1000 mL) per cartridge, DermaRite Industries LLC, 7777 West Side Avenue, North Bergen, NJ 07047.  NDC 61924-093-34", "product_quantity": "6,973 cartridges", "reason_for_recall": "Microbial Contamination of Non-Sterile Drug Product: The products were found to be contaminated with the bacteria Burkholderia cepecia.", "recall_initiation_date": "20250717", "center_classification_date": "20250902", "report_date": "20250910", "code_info": "Lot #: 30705A, Exp. Date 8/2025; 30771A, Exp. Date 9/2025; 30920A, Exp. Date 10/2025; 40016A, Exp. Date 1/2026; 40303A, Exp. Date 4/2026; 40428A, Exp. Date 5/2026; 40505A, Exp. Date 6/2026; 41053C, 41053A, 41053B, Exp. Date 12/2026, 50017A, Exp. Date 1/2027."}, {"status": "Ongoing", "city": "Hawthorne", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96508", "recalling_firm": "Alchemee, LLC", "address_1": "3 Skyline Dr", "address_2": "N/A", "postal_code": "10532-2174", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0360-2025", "product_description": "Proactiv Skin Smoothing Exfoliator (Benzoyl Peroxide 2.5%), Packaged as a) 6 fl. oz. (177.4 mL), UPC 7 35786 01528 2; b) 0.33 OZ (9.45g), UPC 8 42944 10223 1; Distributed by Alchemee, LLC, Santa Monica, CA 90401,", "product_quantity": "3,500 bottles", "reason_for_recall": "Chemical contamination: Presence of benzene", "recall_initiation_date": "20250312", "center_classification_date": "20250409", "report_date": "20250416", "code_info": "Lot, V4204A, Exp 07/31/2025"}, {"status": "Ongoing", "city": "Ta. Kadi, District Mehsana", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {"application_number": ["M030"], "brand_name": ["KINGSKIN SACA CALLOS"], "generic_name": ["SALICYLIC ACID"], "manufacturer_name": ["Pharmadel LLC"], "product_ndc": ["55758-423"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["SALICYLIC ACID"], "rxcui": ["312881"], "spl_id": ["32ed3823-8328-609f-e063-6294a90a3fa8"], "spl_set_id": ["1d9fc86a-7e9b-4ea4-e063-6294a90a531c"], "package_ndc": ["55758-423-15"], "is_original_packager": [true], "unii": ["O414PZ4LPZ"], "upc": ["810096771636"]}, "product_type": "Drugs", "event_id": "96797", "recalling_firm": "KENIL HEALTHCARE PRIVATE LIMITED", "address_1": "Plot 319", "address_2": "Village Acharasan, Ankhol-Vamaj Road", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "DE and NC", "recall_number": "D-0424-2025", "product_description": "Kingskin, SacaCallos, 17% Salicylic acid, 0.5 fl oz (14.8mL) Bottle, Dist. by: Pharmadel LLC, New Castle, DE 19720, Made in India, NDC 55758-423-15, UPC 8 10096 77163 6.", "product_quantity": "9,000 Bottles", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250424", "center_classification_date": "20250519", "report_date": "20250528", "code_info": "Lot SP28A, Exp Date: 09/30/2026"}, {"status": "Ongoing", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA214484"], "brand_name": ["LISDEXAMFETAMINE DIMESYLATE"], "generic_name": ["LISDEXAMFETAMINE DIMESYLATE"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "product_ndc": ["57664-046", "57664-047", "57664-048", "57664-049", "57664-050", "57664-051", "57664-052", "57664-083", "57664-084", "57664-085", "57664-086", "57664-087", "57664-088"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LISDEXAMFETAMINE DIMESYLATE"], "rxcui": ["854830", "854834", "854838", "854842", "854846", "854850", "1593856", "1871456", "1871460", "1871462", "1871464", "1871466", "1871468"], "spl_id": ["0b77417a-5789-8818-e063-6294a90ad2e3"], "spl_set_id": ["da3148af-f9b6-4725-adae-3595b4c7dc4b"], "package_ndc": ["57664-047-88", "57664-046-88", "57664-048-88", "57664-049-88", "57664-050-88", "57664-051-88", "57664-052-88", "57664-083-88", "57664-084-88", "57664-085-88", "57664-086-88", "57664-087-88", "57664-088-88"], "is_original_packager": [true], "unii": ["SJT761GEGS"]}, "product_type": "Drugs", "event_id": "97092", "recalling_firm": "SUN PHARMACEUTICAL INDUSTRIES INC", "address_1": "2 Independence Way", "address_2": "N/A", "postal_code": "08540-6620", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Recalled units were distributed to 17 distributors who may have further distributed the product nationwide.", "recall_number": "D-0516-2025", "product_description": "Lisdexamfetamine Dimesylate Capsules, 60 mg,\tCII, 100-count bottles, Rx only, Manufactured by: OHM Laboratories, New Brunswick, NJ 08901, Distributed by: Sun Pharmaceuticals, Inc., Cranbury, NJ 08512, NDC 57664-051-88", "product_quantity": "5,448 bottles", "reason_for_recall": "Failed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 9 month long term stability station (25\u00bfC, 60%RH).", "recall_initiation_date": "20250616", "center_classification_date": "20250711", "report_date": "20250723", "code_info": "Lot # AD42648, Exp 02/28/2026"}, {"status": "Ongoing", "city": "Ta. Kadi, District Mehsana", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {"application_number": ["M021"], "brand_name": ["NATURE MINT ANTICAVITY"], "generic_name": ["SODIUM MONOFLUOROPHOSPHATE"], "manufacturer_name": ["Bob Barker Company Inc."], "product_ndc": ["53247-131"], "product_type": ["HUMAN OTC DRUG"], "route": ["DENTAL"], "substance_name": ["SODIUM MONOFLUOROPHOSPHATE"], "rxcui": ["545626"], "spl_id": ["25cae217-37ed-403c-8a97-acfae13ef681"], "spl_set_id": ["39e9c844-d2c2-4e3c-84c0-bdb767a03f7b"], "package_ndc": ["53247-131-01", "53247-131-02", "53247-131-03", "53247-131-04", "53247-131-05", "53247-131-06", "53247-131-07"], "is_original_packager": [true], "unii": ["C810JCZ56Q"]}, "product_type": "Drugs", "event_id": "96797", "recalling_firm": "KENIL HEALTHCARE PRIVATE LIMITED", "address_1": "Plot 319", "address_2": "Village Acharasan, Ankhol-Vamaj Road", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "DE and NC", "recall_number": "D-0435-2025", "product_description": "Nature Mint, Anticavity Fluoride Toothpaste, Sodium monofluorophosphate 0.76%, NET WT 4.6 OZ (130 grams) Tube, Made in India, Dist. by Bob Barker Co. Inc., Fuquay-Varina, NC 27526, NDC 53247-131-06", "product_quantity": "19,500 Tubes", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250424", "center_classification_date": "20250519", "report_date": "20250528", "code_info": "Lot B0027, B0031, Exp Date: 06/30/2026; Lot B0032, Exp Date: 07/31/2026"}, {"status": "Ongoing", "city": "Pulaski", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA209755"], "brand_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "generic_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "manufacturer_name": ["AvPAK"], "product_ndc": ["50268-162", "50268-163", "50268-164", "50268-165", "50268-166"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "rxcui": ["991039", "991044", "991188", "991194", "991336"], "spl_id": ["0e85a5c9-76a9-f621-e063-6394a90a8782"], "spl_set_id": ["9e8cebc0-7fcf-dca8-e053-2a95a90a3369"], "package_ndc": ["50268-162-11", "50268-162-15", "50268-163-11", "50268-163-15", "50268-164-11", "50268-164-15", "50268-165-11", "50268-165-15", "50268-166-11", "50268-166-12"], "original_packager_product_ndc": ["69238-1054", "69238-1056", "69238-1058", "69238-1060", "69238-1062"], "unii": ["9WP59609J6"]}, "product_type": "Drugs", "event_id": "97548", "recalling_firm": "AvKARE", "address_1": "615 N 1st St", "address_2": "N/A", "postal_code": "38478-2403", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "USA Nationwide", "recall_number": "D-0644-2025", "product_description": "chloroproMAZINE Hydrochloride Tablets, USP, 100 mg, 50 Tablets (5x10) unit dose carton, Rx only, Manufactured for: AvKare, Pulaski, TN, 38478, NDC 50268-165-15", "product_quantity": "2003 cartons", "reason_for_recall": "Presence of a foreign substance.", "recall_initiation_date": "20250825", "center_classification_date": "20250911", "report_date": "20250917", "code_info": "Lot # 47089, Exp 12/31/25; 47604, Exp 03/31/26"}, {"status": "Ongoing", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA209755"], "brand_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "generic_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "manufacturer_name": ["American Health Packaging"], "product_ndc": ["60687-419", "60687-430", "60687-441", "60687-452", "60687-463"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "rxcui": ["991039", "991044", "991188", "991194", "991336"], "spl_id": ["19336340-ad22-62b7-e063-6294a90affed"], "spl_set_id": ["d43718e5-66d7-44f9-9fc8-80d38d3e41ce"], "package_ndc": ["60687-419-11", "60687-419-01", "60687-430-11", "60687-430-01", "60687-430-65", "60687-441-11", "60687-441-01", "60687-452-11", "60687-452-01", "60687-463-11", "60687-463-01"], "original_packager_product_ndc": ["69238-1054", "69238-1056", "69238-1058", "69238-1060", "69238-1062"], "unii": ["9WP59609J6"]}, "product_type": "Drugs", "event_id": "97533", "recalling_firm": "Amerisource Health Services LLC", "address_1": "2550 John Glenn Ave Ste A", "address_2": "N/A", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0649-2025", "product_description": "chlorproMAZINE Hydrochloride Tablets, USP, 100 mg, 100 (10x10) blisterpack per carton, Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217.  Carton NDC#: 60687-452-01 (Individual unit dose blister pack NDC: 60687-452-11)", "product_quantity": "1,757 cartons", "reason_for_recall": "Presence of a foreign substance.A specific lot of auxiliary polyester coil, used in product packaging at the manufacturing site, was detected with presence of a micro-organism. No micro-organism was detected on any tablets.", "recall_initiation_date": "20250827", "center_classification_date": "20250915", "report_date": "20250924", "code_info": "Lot: 1021652, Exp 10/31/2026; 1022539, Exp 01/31/2027; 1023666, Exp 03/31/2027"}, {"status": "Ongoing", "city": "Kirkland", "state": "WA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "97292", "recalling_firm": "AEQUITA PHARMACY", "address_1": "12825 Ne 126th Pl", "address_2": "N/A", "postal_code": "98034-7721", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "MA", "recall_number": "D-0558-2025", "product_description": "Tirzepatide + Niacinamide 11.24 mg + 1.0mg/0.5 mL Inj Sol,  Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2 mL Multi Dose Vial, Refrigerate, Do not freeze, Aequita Pharmacy LLC, Kirkland, WA 98034.", "product_quantity": "146 vials", "reason_for_recall": "Lack of Processing Controls.", "recall_initiation_date": "20250718", "center_classification_date": "20250801", "report_date": "20250813", "code_info": "All Lots within expiry.", "more_code_info": ""}, {"status": "Ongoing", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA209101"], "brand_name": ["HALOPERIDOL DECANOATE"], "generic_name": ["HALOPERIDOL DECANOATE"], "manufacturer_name": ["BluePoint Laboratories"], "product_ndc": ["68001-578", "68001-579", "68001-580", "68001-581", "68001-582"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR"], "substance_name": ["HALOPERIDOL DECANOATE"], "rxcui": ["859871", "1719803", "1719862"], "spl_id": ["048557ea-f859-f0f2-e063-6294a90af5ab"], "spl_set_id": ["f2d14406-2ad4-4c5b-9c24-a026f27b415d"], "package_ndc": ["68001-579-59", "68001-579-48", "68001-580-41", "68001-581-41", "68001-581-48", "68001-581-82", "68001-578-59", "68001-578-48", "68001-582-41"], "is_original_packager": [true], "upc": ["0368001578592", "0368001581417", "0368001579599", "0368001582414"], "unii": ["AC20PJ4101"]}, "product_type": "Drugs", "event_id": "96636", "recalling_firm": "Amerisource Health Services LLC", "address_1": "2550 John Glenn Ave Ste A", "address_2": "N/A", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0367-2025", "product_description": "Haloperidol Decanoate Injection, 50mg/mL* , 1 mL Single-Dose Vial, Rx only, Manufactured by Somerset Therapeutics Limited, 54/1, Boodhihal Village, Nelamangala, Bangalore - 562123, Karnataka, India, Manufactured for: BluePoint Laboratories, NDC 68001-580-41.", "product_quantity": "2,110 vials", "reason_for_recall": "Lack of assurance of sterility. Bacterial contamination detected in some media fill units", "recall_initiation_date": "20250402", "center_classification_date": "20250418", "report_date": "20250430", "code_info": "A240467B, EXP 07/31/2026"}, {"status": "Ongoing", "city": "Baltimore", "state": "MD", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA209713"], "brand_name": ["LEVOTHYROXINE SODIUM"], "generic_name": ["LEVOTHYROXINE SODIUM"], "manufacturer_name": ["Lupin Pharmaceuticals, Inc."], "product_ndc": ["68180-965", "68180-966", "68180-967", "68180-968", "68180-969", "68180-970", "68180-971", "68180-972", "68180-973", "68180-974", "68180-975", "68180-976"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVOTHYROXINE SODIUM"], "rxcui": ["892246", "892251", "892255", "966220", "966221", "966222", "966224", "966225", "966248", "966249", "966253", "966270"], "spl_id": ["94052e3d-58b2-4f4b-8223-a47281c1a592"], "spl_set_id": ["18717e58-89fb-4e2f-93b6-d6ac3e988d37"], "package_ndc": ["68180-965-03", "68180-965-02", "68180-965-09", "68180-965-01", "68180-966-03", "68180-966-02", "68180-966-09", "68180-966-01", "68180-967-03", "68180-967-02", "68180-967-09", "68180-967-01", "68180-968-09", "68180-968-02", "68180-968-01", "68180-968-03", "68180-969-01", "68180-969-02", "68180-969-03", "68180-969-09", "68180-970-01", "68180-970-02", "68180-970-03", "68180-970-09", "68180-971-01", "68180-971-02", "68180-971-03", "68180-971-09", "68180-972-01", "68180-972-02", "68180-972-03", "68180-972-09", "68180-973-01", "68180-973-02", "68180-973-03", "68180-973-09", "68180-974-01", "68180-974-02", "68180-974-03", "68180-974-09", "68180-975-03", "68180-975-02", "68180-975-01", "68180-975-09", "68180-976-01", "68180-976-02", "68180-976-03", "68180-976-09"], "is_original_packager": [true], "upc": ["0368180973010", "0368180971016", "0368180972013", "0368180969013", "0368180966012", "0368180970019", "0368180968016", "0368180967019", "0368180965015", "0368180976011", "0368180974017"], "unii": ["9J765S329G"]}, "product_type": "Drugs", "event_id": "95892", "recalling_firm": "Lupin Pharmaceuticals Inc.", "address_1": "Harborplace Tower", "address_2": "111 S Calvert St Fl 21st", "postal_code": "21202-6174", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "One US distributor in Ohio.", "recall_number": "D-0167-2025", "product_description": "Levothyroxine Sodium Tablets, Lupin, 75 mcg (0.075mg), 1000 Tablets, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202 United States, Manufactured by: Lupin Limited, Pithampur (M.P)- 454 775 INDIA, NDC# 68180-967-03", "product_quantity": "480 1000-count bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications: Out of specifications result observed in the drug substance for impurity test during 3-month long term stability study.", "recall_initiation_date": "20241220", "center_classification_date": "20241230", "report_date": "20250108", "code_info": "Lot# LA01276, Exp Date: 07/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Historic New Castle", "state": "DE", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M028"], "brand_name": ["KINGSKIN"], "generic_name": ["SALICYLIC ACID"], "manufacturer_name": ["Pharmadel LLC"], "product_ndc": ["55758-409"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["SALICYLIC ACID"], "rxcui": ["312881"], "spl_id": ["30de65a3-4991-e4d0-e063-6294a90a728c"], "spl_set_id": ["09974c86-6fba-3f20-e063-6294a90abd89"], "package_ndc": ["55758-409-15"], "is_original_packager": [true], "unii": ["O414PZ4LPZ"]}, "product_type": "Drugs", "event_id": "96639", "recalling_firm": "Pharmadel, LLC", "address_1": "650 Centerpoint Blvd", "address_2": "N/A", "postal_code": "19720-8108", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "DE", "recall_number": "D-0381-2025", "product_description": "Kingskin, Elimina Las Verrugas, For the removal of common warts, 0.50 oz fl (15 mL), Distributed by: Pharmadel, New Castle, DE 19720, NDC 55758-409-15", "product_quantity": "20,048 bottles", "reason_for_recall": "cGMP deviations", "recall_initiation_date": "20250415", "center_classification_date": "20250421", "report_date": "20250430", "code_info": "Lot, expiry: KSE-01, EXP: OCT 26; KSE-02, EXP: FEB 27"}, {"status": "Ongoing", "city": "Panchmahal", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {"application_number": ["ANDA215076"], "brand_name": ["DOXEPIN HYDROCHLORIDE"], "generic_name": ["DOXEPIN HYDROCHLORIDE"], "manufacturer_name": ["Alembic Pharmaceuticals Inc."], "product_ndc": ["62332-637", "62332-638", "62332-645", "62332-639", "62332-640"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DOXEPIN HYDROCHLORIDE"], "rxcui": ["1000048", "1000058", "1000070", "1000076", "1000097"], "spl_id": ["c3977b05-a9fc-4cc4-adfc-731abe6613dd"], "spl_set_id": ["4920401a-cde5-404b-82aa-c3c0e8911065"], "package_ndc": ["62332-637-31", "62332-637-91", "62332-638-31", "62332-638-91", "62332-645-31", "62332-645-91", "62332-639-31", "62332-639-91", "62332-640-31", "62332-640-91", "2305015142"], "is_original_packager": [true], "upc": ["0362332645312"], "unii": ["3U9A0FE9N5"]}, "product_type": "Drugs", "event_id": "97323", "recalling_firm": "Alembic Pharmaceuticals Limited", "address_1": "Formulation Division, Village Panelav, P.O. Tajpura, Near Baska, Taluka Halol", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0566-2025", "product_description": "Doxepin Hydrochloride Capsules, USP, 10 mg, 100 Capsules, Rx only, Manufactured by: Alembic Pharmaceuticals Limited, Panela v 389350, Gujarat, India, Manufactured for: Alembic Pharmaceuticals, Inc., Bedminster, NJ 07921, USA, NDC 62332-637-31", "product_quantity": "9,492 bottles", "reason_for_recall": "CGMP Deviations: Presence of Nitrosamine Drug Substance Related Impurity above the proposed interim limit.", "recall_initiation_date": "20250725", "center_classification_date": "20250801", "report_date": "20250813", "code_info": "Lot: 2305015142, Exp. Date: 9/30/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "La Vergne", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA213368"], "brand_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "generic_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "manufacturer_name": ["Major Pharmaceuticals"], "product_ndc": ["0904-7129", "0904-7130", "0904-7131", "0904-7132", "0904-7133"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "rxcui": ["991039", "991044", "991188", "991194", "991336"], "spl_id": ["be5824c1-1eca-44db-a689-c67b9808c1f9"], "spl_set_id": ["d58570a0-58b0-4662-b2ad-aa8d1463b4c1"], "package_ndc": ["0904-7129-61", "0904-7130-61", "0904-7130-06", "0904-7131-61", "0904-7132-61", "0904-7133-61", "0030904713"], "original_packager_product_ndc": ["70710-1129", "70710-1130", "70710-1131", "70710-1132", "70710-1133"], "unii": ["9WP59609J6"]}, "product_type": "Drugs", "event_id": "97584", "recalling_firm": "The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories", "address_1": "341 Mason Rd", "address_2": "", "postal_code": "37086-3606", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0009-2026", "product_description": "Major ChlorproMAZINE Hydrochloride Tablets, USP, 25 mg, 50 Tablets (5x10) blister package, Rx Only, Packaged and Distributed by Major Pharmaceuticals, Indianapolis, IN 46268, USA, NDC 0904-7130-06, UPC (01)00309047130061", "product_quantity": "2064 blister packs", "reason_for_recall": "CGMP Deviations: Presence of N-Nitroso Desmethyl Chlorpromazine above the recommended intake limit", "recall_initiation_date": "20250912", "center_classification_date": "20251007", "report_date": "20251015", "code_info": "Lots N01943 and Lot N02025, exp. date 02/28/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "New York", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA209359"], "brand_name": ["EPINEPHRINE"], "generic_name": ["EPINEPHRINE"], "manufacturer_name": ["Hospira, Inc."], "product_ndc": ["0409-4933"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["EPINEPHRINE"], "rxcui": ["727373"], "spl_id": ["89ecdc19-31ff-40e9-93aa-a916bef2b462"], "spl_set_id": ["ef18a92f-ba83-4bb0-808b-d09d736f6a81"], "package_ndc": ["0409-4933-11", "0409-4933-01", "0409-4933-05", "0409-4933-10"], "is_original_packager": [true], "nui": ["N0000000209", "N0000000245", "N0000175552", "N0000175555", "N0000175570", "M0003647"], "pharm_class_moa": ["Adrenergic alpha-Agonists [MoA]", "Adrenergic beta-Agonists [MoA]"], "pharm_class_epc": ["alpha-Adrenergic Agonist [EPC]", "beta-Adrenergic Agonist [EPC]", "Catecholamine [EPC]"], "pharm_class_cs": ["Catecholamines [CS]"], "unii": ["YKH834O4BH"]}, "product_type": "Drugs", "event_id": "97364", "recalling_firm": "PFIZER INC", "address_1": "68 Hudson Blvd E", "address_2": "N/A", "postal_code": "10001-2188", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0590-2025", "product_description": "Vial Label: Epinephrine Injection, USP, 1mg/10mL (0.1 mg/mL), Rx only, Distributed by Hospira, Inc., Lake Forest, IL 60045, USA. NDC 0409-4933-05.  Case: NDC 0409-4933-10.", "product_quantity": "49,620 vials", "reason_for_recall": "Lack of Assurance of Sterility.", "recall_initiation_date": "20250804", "center_classification_date": "20250818", "report_date": "20250827", "code_info": "Lot #: LY3681, LY4360, LY4416, Exp. 02/28/2026"}, {"status": "Ongoing", "city": "Clark", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96390", "recalling_firm": "L'Oreal USA", "address_1": "222 Terminal Ave", "address_2": "", "postal_code": "07066-1317", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0418-2025", "product_description": "La Roche-Posay Laboratoire Dermatologique Effaclar Dermatological Acne System, 3 Step Acne Routine Kit, Medicated Gel Cleanser 3.4 fl. oz. (100 mL) Tube, Clarifying Solution 3.4 fl. oz. (100 mL) Tube, Dual Action Acne Treatment 0.7 fl. oz. (20 mL: UPC 883140035275) Tube, (benzoyl peroxide 0.5% and benzoyl peroxide 5.5% and salicylic acid 2%), La Roche-Posay LLC, 10 Hudson Yards, New York, NY 10001, La Roche-Posay, France, UPC 883140035282 (kit).", "product_quantity": "14,460 bottles", "reason_for_recall": "cGMP Deviations: The recall was initiated due to detected trace levels of benzene in a specific lot of this product lot (MYX46W), however out of an abundance of caution, the firm voluntarily recalled all La Roche-Posay Effaclar Duo Dual Action Acne Treatment lots.", "recall_initiation_date": "20250305", "center_classification_date": "20250509", "report_date": "20250521", "code_info": "Lot #s, Expiration Dates: MYX30W, Exp 03/31/2025 MYX32W, Exp 03/31/2025 MYX33W, Exp 03/31/2025 MYX41W, Exp 04/30/2025 MYX42W, Exp 04/30/2025 MYX43W, Exp 04/30/2025 MYX44W, Exp 04/30/2025 MYX45W, Exp 04/30/2025 MYX50W, Exp 05/31/2025 MYX51W, Exp 04/30/2025 MYX52W, Exp 04/30/2025 MYX53W, Exp 05/31/2025 MYX70W, Exp 07/31/2025 MYX80W, Exp 07/31/2025 MYX81W, Exp 07/31/2025 MYX90W, Exp 08/31/2025 MYX91W, Exp 08/31/2025 MYX92W, Exp 08/31/2025 MYX93W, Exp 08/31/2025 MYXD0W, Exp 09/30/2025 MYXO1W, Exp 09/30/2025 MYXO2W, Exp 09/30/2025 MYXO3W, Exp 09/30/2025 MYXO4W, Exp 09/30/2025 MYXO5W, Exp 09/30/2025 MYY21W, Exp 02/28/2026 MYY23W, Exp 02/28/2026 MYY26W, Exp 02/28/2026 MYY27W, Exp 02/28/2026 MYY31W, Exp 03/31/2026 MYY32W, Exp 11/30/2025 MYY33W, Exp 11/30/2025 MYY34W, Exp 03/31/2026 MYY50W, Exp 05/31/2026 MYY51W, Exp 05/31/2026 MYY60W, Exp 05/31/2026 MYY61W, Exp 03/31/2026 MYY62W, Exp 06/30/2026 MYY63W, Exp 06/30/2026 MYY64W, Exp 06/30/2026 MYY72W, Exp 06/30/2026 MYY73W, Exp 06/30/2026 MYY74W, Exp 06/30/2026 MYY75W, Exp 06/30/2026 MYY76W, Exp 06/30/2026.", "more_code_info": ""}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA205268"], "brand_name": ["PROPAFENONE HYDROCHLORIDE"], "generic_name": ["PROPAFENONE HYDROCHLORIDE"], "manufacturer_name": ["Northstar Rx LLC"], "product_ndc": ["16714-825", "16714-826", "16714-827"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["PROPAFENONE HYDROCHLORIDE"], "rxcui": ["861156", "861164", "861171"], "spl_id": ["59aaf0aa-9074-4563-93ba-1c97e76352a2"], "spl_set_id": ["2ecd6452-ccc3-493f-9a4a-69f0fbf67a42"], "package_ndc": ["16714-825-01", "16714-826-01", "16714-827-01"], "is_original_packager": [true], "upc": ["0316714826011", "0316714827018", "0316714825014"], "unii": ["33XCH0HOCD"]}, "product_type": "Drugs", "event_id": "96474", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0351-2025", "product_description": "Propafenone Hydrochloride Extended-Release Capsules USP, 225mg 60-count bottles, Rx Only, Mfd by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India. NDC# 16714-825-01.", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250313", "center_classification_date": "20250408", "report_date": "20250416", "code_info": "Lot #  17230819, exp. date Mar-25"}, {"status": "Ongoing", "city": "Englewood", "state": "CO", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96742", "recalling_firm": "Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado)", "address_1": "88 Inverness Cir E Unit A204", "address_2": "", "postal_code": "80112-5521", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "USA Nationwide", "recall_number": "D-0486-2025", "product_description": "Tirzepatide/Cyanocobalamin Injectable, 30mg/1mg/mL (15mg/0.5mg/0.5mL), pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewood, CO 80112", "product_quantity": "242 syringes", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20250521", "center_classification_date": "20250620", "report_date": "20250702", "code_info": "Lot: C03125A", "more_code_info": ""}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA079019"], "brand_name": ["ATOMOXETINE"], "generic_name": ["ATOMOXETINE"], "manufacturer_name": ["Northstar Rx LLC"], "product_ndc": ["16714-755", "16714-756", "16714-757", "16714-758", "16714-759", "16714-760", "16714-761"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ATOMOXETINE HYDROCHLORIDE"], "rxcui": ["349591", "349592", "349593", "349594", "349595", "608139", "608143"], "spl_id": ["fc2fb27b-9a53-4df1-874e-bb2ed5157aef"], "spl_set_id": ["133a4b65-762b-4712-baba-2442546f0379"], "package_ndc": ["16714-755-01", "16714-756-01", "16714-757-01", "16714-758-01", "16714-759-01", "16714-760-01", "16714-761-01"], "is_original_packager": [true], "upc": ["0316714761015", "0316714758015", "0316714759012", "0316714757018", "0316714760018", "0316714755014", "0316714756011"], "unii": ["57WVB6I2W0"]}, "product_type": "Drugs", "event_id": "96194", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the U.S", "recall_number": "D-0240-2025", "product_description": "Atomoxetine Capsules, USP, 25 mg, 30 capsule bottles, Rx Only, Manufactured for: Northstar Rx LLC., Memphis, TN 38141, Manufactured by: Glenmark Pharmaceuticals Ltd., Goa, India, NDC 16714-757-01.", "product_quantity": "133,824 bottles", "reason_for_recall": "CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.", "recall_initiation_date": "20250129", "center_classification_date": "20250220", "report_date": "20250226", "code_info": "Lot Numbers: 19232506, 19232397, 19232415, Exp.: 5/2025; 19233791, Exp.: 8/2025; 19234248, Exp.: 9/2025; 19240909, Exp.: 2/2026; 19242598, Exp.:6/2026; 19243163, 19243122, Exp.: 7/2026; 19243884, Exp.: 9/2026."}, {"status": "Ongoing", "city": "Ledgewood", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "97183", "recalling_firm": "Imprimis NJOF, LLC", "address_1": "1705 Route 46 Ste 6B", "address_2": "N/A", "postal_code": "07852-9720", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0535-2025", "product_description": "Epinephrine Lidocaine HCL, 0.25mg/mL and 7.5 mg/mL, 20x1 mL Vials per carton, Rx Only, Imprimis NJOF, 1705  Route 46 West, Unit 6B Ledgewood, NJ, 07852 NDC: 71384-641-01", "product_quantity": "6,880 vials", "reason_for_recall": "Sub-Potent Drug: Subpotent assay results during stability testing.", "recall_initiation_date": "20250709", "center_classification_date": "20250721", "report_date": "20250730", "code_info": "Lot: 24DEC017, Exp. 07/12/2025."}, {"status": "Ongoing", "city": "Bengaluru", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {"application_number": ["ANDA209101"], "brand_name": ["HALOPERIDOL DECANOATE"], "generic_name": ["HALOPERIDOL DECANOATE"], "manufacturer_name": ["Somerset Therapeutics, LLC"], "product_ndc": ["70069-030", "70069-031", "70069-381", "70069-382", "70069-383", "70069-384"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR"], "substance_name": ["HALOPERIDOL DECANOATE"], "rxcui": ["859867", "859871", "1719803", "1719862"], "spl_id": ["f6d888a0-65a7-4073-8671-b00b4bfaff4c"], "spl_set_id": ["f2bff27f-929f-4f7d-b3eb-084ebc2a885f"], "package_ndc": ["70069-030-05", "70069-030-03", "70069-031-01", "70069-031-05", "70069-381-01", "70069-381-10", "70069-382-01", "70069-382-05", "70069-383-05", "70069-383-10", "70069-383-01", "70069-384-01", "70069-384-05"], "is_original_packager": [true], "upc": ["0370069382011", "0370069383018", "0370069031018", "0370069030011", "0370069384015"], "unii": ["AC20PJ4101"]}, "product_type": "Drugs", "event_id": "96569", "recalling_firm": "Somerset Therapeutics Private Limited", "address_1": "54/1 Budihal Village", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0358-2025", "product_description": "Haloperidol Decanoate Injection, 100 mg/mL, 1mL Single-Dose Vial, Rx Only, Manufactured for: Somerset Therapeutics, LLC, Somerset, NJ 08873, NDC 70069-383-10", "product_quantity": "240 vials", "reason_for_recall": "Lack of Assurance of Sterility: Media fill with bacterial contamination", "recall_initiation_date": "20250321", "center_classification_date": "20250408", "report_date": "20250416", "code_info": "A240482D, exp. date 08/2026"}, {"status": "Ongoing", "city": "Historic New Castle", "state": "DE", "country": "United States", "classification": "Class II", "openfda": {"brand_name": ["RAPIDOL ARNICA"], "generic_name": ["ARNICA MONTANA"], "manufacturer_name": ["Pharmadel LLC"], "product_ndc": ["55758-403"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["ARNICA MONTANA WHOLE"], "spl_id": ["0517e283-81da-5b52-e063-6294a90a4eaf"], "spl_set_id": ["0517e283-81d9-5b52-e063-6294a90a4eaf"], "package_ndc": ["55758-403-02"], "is_original_packager": [true], "unii": ["O80TY208ZW"]}, "product_type": "Drugs", "event_id": "96639", "recalling_firm": "Pharmadel, LLC", "address_1": "650 Centerpoint Blvd", "address_2": "N/A", "postal_code": "19720-8108", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "DE", "recall_number": "D-0382-2025", "product_description": "Rapidol Arnica Gel, Topical Gel, Homeopathic Medicine, 2 oz (57 g), Distributed by: Pharmadel, New Castle, DE 19720, NDC 55758-403-02", "product_quantity": "6,048 bottles", "reason_for_recall": "cGMP deviations", "recall_initiation_date": "20250415", "center_classification_date": "20250421", "report_date": "20250430", "code_info": "Lot, expiry: EAG-01, EXP: MAR 27"}, {"status": "Ongoing", "city": "Northfield", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M003"], "brand_name": ["CURAD ALCOHOL PREP PADS"], "generic_name": ["ISOPROPYL ALCOHOL"], "manufacturer_name": ["Medline Industries, LP"], "product_ndc": ["53329-827"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["ISOPROPYL ALCOHOL"], "rxcui": ["797544"], "spl_id": ["4139066c-97a1-6d62-e063-6394a90a76e7"], "spl_set_id": ["1ce3872e-2307-4a38-bd7d-7eb2b226cf3c"], "package_ndc": ["53329-827-60", "53329-827-36", "53329-827-30", "53329-827-29", "53329-827-40", "53329-827-09", "53329-827-33", "6122405000"], "is_original_packager": [true], "unii": ["ND2M416302"]}, "product_type": "Drugs", "event_id": "96404", "recalling_firm": "MEDLINE INDUSTRIES, LP - Northfield", "address_1": "3 Lakes Dr", "address_2": "N/A", "postal_code": "60093-2753", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "Nationwide", "recall_number": "D-0289-2025", "product_description": "CURAD Alcohol Prep Pads, Sterile, Medium, 2-Ply, Contents: 5 boxes per Carton, 30 Boxes per Case, Single Use Only, Manufactured for Medline Industries, LP, Three Lakes Drive, Northfield, IL 60093, USA, Made in India, www.curad.com, 1-800-633-5463, NDC 53329-827-30.", "product_quantity": "1,639,996 pads", "reason_for_recall": "Subpotent Drug", "recall_initiation_date": "20250217", "center_classification_date": "20250320", "report_date": "20250326", "code_info": "SKU: CUR090737RB, Lot: 61224050002"}, {"status": "Ongoing", "city": "Irving", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["BLA125544"], "brand_name": ["INFLECTRA"], "generic_name": ["INFLIXIMAB-DYYB"], "manufacturer_name": ["Pfizer Laboratories Div Pfizer Inc"], "product_ndc": ["0069-0809"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["INFLIXIMAB"], "rxcui": ["1790541", "1790546"], "spl_id": ["421960f4-55cd-4bf8-9f00-b980b020e7a7"], "spl_set_id": ["37eaca10-d812-48bc-8b8e-b836bfa9968f"], "package_ndc": ["0069-0809-01"], "is_original_packager": [true], "upc": ["0300690809014"], "nui": ["N0000175610", "N0000175451"], "pharm_class_epc": ["Tumor Necrosis Factor Blocker [EPC]"], "pharm_class_moa": ["Tumor Necrosis Factor Receptor Blocking Activity [MoA]"], "unii": ["B72HH48FLU"]}, "product_type": "Drugs", "event_id": "96167", "recalling_firm": "McKesson", "address_1": "6555 State Highway 161", "address_2": "", "postal_code": "75039-2402", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0213-2025", "product_description": "Inflectra (infliximab-dyyb), For injection, 100mg per vial, packaged in 10 mL single-dose vial, Rx only, Mfd by: CELLTRION, INC, Dist. by: Pfizer Labs, Division of Pfizer Inc., New York, NY 10001, NDC 0069-0809-01", "product_quantity": "192 vials", "reason_for_recall": "cGMP Deviations: Product intended for quarantine was inadvertently distributed.", "recall_initiation_date": "20250117", "center_classification_date": "20250130", "report_date": "20250205", "code_info": "Lot# 04647349, Exp Date 5/31/2029", "more_code_info": ""}, {"status": "Ongoing", "city": "Canoga Park", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "97558", "recalling_firm": "Private Label Skin Care Inc.", "address_1": "8200 Remmet Ave", "address_2": "N/A", "postal_code": "91304-4156", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "CA, GA only", "recall_number": "D-0666-2025", "product_description": "mel rx Skin, NO DRAMA Benzoyl Peroxide 10% Acne Treatment, 7 oz, 201 g Mel Skin Rx Beverly Hills, CA 90210", "product_quantity": "N/A", "reason_for_recall": "Chemical Contamination: This recall has been initiated due to elevated levels of benzene that was discovered during post consume awareness with benzoyl peroxide products.", "recall_initiation_date": "20250912", "center_classification_date": "20250924", "report_date": "20251001", "code_info": "Lot # 58170A and 58172A, Exp Date: 09/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["NDA020161"], "brand_name": ["POTASSIUM CHLORIDE"], "generic_name": ["POTASSIUM CHLORIDE"], "manufacturer_name": ["ICU Medical Inc."], "product_ndc": ["0990-7074", "0990-7075", "0990-7077"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["POTASSIUM CHLORIDE"], "rxcui": ["312507", "1860239", "1860241", "1860463", "1860466"], "spl_id": ["88bcbbe4-9ebf-4491-874a-c4c4c7f1f90d"], "spl_set_id": ["eb56a807-ea94-4edb-9811-a04b19568468"], "package_ndc": ["0990-7074-26", "0990-7075-14", "0990-7075-26", "0990-7077-14", "0990-7077-26", "0030990707"], "is_original_packager": [true], "unii": ["660YQ98I10"]}, "product_type": "Drugs", "event_id": "96250", "recalling_firm": "ICU Medical, Inc.", "address_1": "600 N Field Dr", "address_2": "", "postal_code": "60045-4835", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0268-2025", "product_description": "POTASSIUM CHLORIDE Inj., 10 mEq total in 100 mL, 100 mEq/L flexible container, Rx Only, ICU Medical, Inc., Lake Forest, Illinois, 60045, USA, NDC# 0990-7074-26; Bar Code (01)00309907074269", "product_quantity": "unknown", "reason_for_recall": "Labeling: Label Error on Declared Strength. Overwrap labeled as Potassium Chloride Inj 10 mEq may contain flexible containers of Potassium Chloride Inj 20 mEq", "recall_initiation_date": "20250213", "center_classification_date": "20250310", "report_date": "20250319", "code_info": "Lot 1023172, Exp Date: 31 January 2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA079019"], "brand_name": ["ATOMOXETINE"], "generic_name": ["ATOMOXETINE"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-265", "68462-266", "68462-267", "68462-268", "68462-269", "68462-270", "68462-271"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ATOMOXETINE HYDROCHLORIDE"], "rxcui": ["349591", "349592", "349593", "349594", "349595", "608139", "608143"], "spl_id": ["84dc1413-a85b-41f6-a3e3-6e76c01f6803"], "spl_set_id": ["0ab8d905-e890-4e91-a730-3e5d12f5c23f"], "package_ndc": ["68462-265-30", "68462-265-23", "68462-266-30", "68462-266-23", "68462-267-30", "68462-267-23", "68462-268-30", "68462-268-23", "68462-269-30", "68462-269-23", "68462-270-30", "68462-270-23", "68462-271-30", "68462-271-51"], "is_original_packager": [true], "upc": ["0368462270301"], "unii": ["57WVB6I2W0"]}, "product_type": "Drugs", "event_id": "96194", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the U.S", "recall_number": "D-0232-2025", "product_description": "Atomoxetine Capsules, USP, 18 mg, 30 capsule bottles, Rx Only, Manufactured for: Glenmark Pharmaceuticals Inc., NJ, USA, Product of India, NDC 68462-266-30.", "product_quantity": "56,208 bottles", "reason_for_recall": "CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.", "recall_initiation_date": "20250129", "center_classification_date": "20250220", "report_date": "20250226", "code_info": "Lot Numbers: 19233756, Exp.: 8/2025; 19235111, Exp.: 11/2025; 19242167, Exp.: 5/2026; 19242180, Exp.: 5/2026."}, {"status": "Ongoing", "city": "Northfield", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M003"], "brand_name": ["WALMART"], "generic_name": ["ISOPROPYL ALCOHOL"], "manufacturer_name": ["Walmart Inc."], "product_ndc": ["49035-814"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["ISOPROPYL ALCOHOL"], "rxcui": ["797544"], "spl_id": ["22655201-3f8c-b00b-e063-6294a90a80f1"], "spl_set_id": ["d2b9f182-c341-c3b0-e053-2a95a90ac5a7"], "package_ndc": ["49035-814-30", "49035-814-60", "6122407007"], "is_original_packager": [true], "unii": ["ND2M416302"]}, "product_type": "Drugs", "event_id": "97385", "recalling_firm": "MEDLINE INDUSTRIES, LP - Northfield", "address_1": "3 Lakes Dr", "address_2": "", "postal_code": "60093-2753", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0602-2025", "product_description": "ReliOn, Sterile Alcohol Swabs, Skin Cleanser, 200 Swabs, Distributed by, Walmart, Inc., Bentonville, AR 72716 Walmart: 200 eaches per box, 24 boxes per case (4,800 eaches per case), NDC 49035-814-60.", "product_quantity": "3,456,000 pads", "reason_for_recall": "Subpotent Drug- isopropyl alcohol levels fall below the labeled concentration.", "recall_initiation_date": "20250707", "center_classification_date": "20250826", "report_date": "20250903", "code_info": "61224070073", "more_code_info": ""}, {"status": "Ongoing", "city": "Bedminster", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA207105"], "brand_name": ["ARIPIPRAZOLE"], "generic_name": ["ARIPIPRAZOLE"], "manufacturer_name": ["Ascend Laboratories, LLC"], "product_ndc": ["67877-430", "67877-431", "67877-432", "67877-433", "67877-434", "67877-435"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ARIPIPRAZOLE"], "spl_id": ["583fc581-09d7-4d4f-a079-08ba9d00f775"], "spl_set_id": ["c7040fef-96a7-4429-9a8e-ec3ab17a8019"], "package_ndc": ["67877-431-03", "67877-431-01", "67877-431-05", "67877-431-33", "67877-431-38", "67877-431-32", "67877-432-03", "67877-432-01", "67877-432-05", "67877-432-33", "67877-432-38", "67877-432-32", "67877-433-03", "67877-433-01", "67877-433-05", "67877-433-33", "67877-433-38", "67877-433-32", "67877-434-03", "67877-434-01", "67877-434-05", "67877-434-33", "67877-434-38", "67877-435-03", "67877-435-01", "67877-435-05", "67877-435-33", "67877-435-38", "67877-430-03", "67877-430-01", "67877-430-05", "67877-430-33", "67877-430-38", "67877-430-32"], "is_original_packager": [true], "nui": ["N0000175430"], "pharm_class_epc": ["Atypical Antipsychotic [EPC]"], "unii": ["82VFR53I78"]}, "product_type": "Drugs", "event_id": "97511", "recalling_firm": "Ascend Laboratories, LLC", "address_1": "135 Us Highway 202 206 Ste 15", "address_2": "N/A", "postal_code": "07921-2608", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0645-2025", "product_description": "Aripiprazole Tablets, USP, 10 mg, 30-count bottles, Rx only, Manufactured by: Alken Laboratories Ltd., INDIA; Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054.  NDC: 67877-432-03", "product_quantity": "2,256  bottles", "reason_for_recall": "Superpotent drug", "recall_initiation_date": "20250828", "center_classification_date": "20250912", "report_date": "20250924", "code_info": "Lot #: 24144162, Exp. Date 09/2027"}, {"status": "Ongoing", "city": "Westborough", "state": "MA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "97345", "recalling_firm": "Atlantic Management Resources Ltd.", "address_1": "39 Harvey Ln", "address_2": "N/A", "postal_code": "01581-3013", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Product was distributed via the internet.", "recall_number": "D-0629-2025", "product_description": "Neuroquell & Neuroquell Plus, .22 fl. Oz (6.6mL),Mfg. For/Dist. By Claire Ellen Products, P.O. Box 901 Westboro, MA 01581 USA, NDC 66233712-01", "product_quantity": "72 containers", "reason_for_recall": "cGMP violations", "recall_initiation_date": "20250827", "center_classification_date": "20250910", "report_date": "20250917", "code_info": "Lot # B-02 Batch #: 1087920520 Product # R937 BBE#31-05-21( May 31, 2021)  Batch # 1087920920  Product # R937 BBE# 31-05-21 (May 31, 2021)"}, {"status": "Ongoing", "city": "Naples", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA209294"], "brand_name": ["CLOMIPRAMINE HYDROCHLORIDE"], "generic_name": ["CLOMIPRAMINE HYDROCHLORIDE CAPSULES"], "manufacturer_name": ["Lupin Pharmaceuticals, Inc."], "product_ndc": ["68180-492", "68180-493", "68180-494"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CLOMIPRAMINE HYDROCHLORIDE"], "rxcui": ["857297", "857301", "857305"], "spl_id": ["7e89336a-0de0-42d6-af70-26345940b81d"], "spl_set_id": ["ebad19b5-e5dd-4f77-ab97-d20ce0f24cb9"], "package_ndc": ["68180-492-01", "68180-492-07", "68180-492-09", "68180-492-06", "68180-493-01", "68180-493-07", "68180-493-09", "68180-493-06", "68180-494-01", "68180-494-07", "68180-494-09", "68180-494-06"], "is_original_packager": [true], "upc": ["0368180494065", "0368180493068"], "unii": ["2LXW0L6GWJ"]}, "product_type": "Drugs", "event_id": "97159", "recalling_firm": "Lupin Pharmaceuticals Inc.", "address_1": "5801 Pelican Bay Blvd", "address_2": "Suite 500", "postal_code": "34108-2755", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-0537-2025", "product_description": "clomiPRAMINE Hydrochloride Capsules USP 25 mg, 100 count bottles, 5801 Pelican Bay Boulevard, Suite 500, Naples, Florida 34108, NDC# 68180-492-01", "product_quantity": "2,724 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications: an out of specification result observed in degradation product test (any unspecified degradation product) during retention sample testing at expiry.", "recall_initiation_date": "20250627", "center_classification_date": "20250721", "report_date": "20250730", "code_info": "Lot # M300464, exp. date June, 2025"}, {"status": "Ongoing", "city": "Historic New Castle", "state": "DE", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96639", "recalling_firm": "Pharmadel, LLC", "address_1": "650 Centerpoint Blvd", "address_2": "N/A", "postal_code": "19720-8108", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "DE", "recall_number": "D-0380-2025", "product_description": "DoloEar Earache Drops, Homeopathic, 0.50 oz fl (15 mL), Distributed by: Pharmadel, New Castle, DE 19720, NDC 55758-401-15", "product_quantity": "27,648 bottles", "reason_for_recall": "cGMP deviations", "recall_initiation_date": "20250415", "center_classification_date": "20250421", "report_date": "20250430", "code_info": "Lot, expiry: DEE-01, EXP: OCT 26;  DEE-02 EXP: FEB 27"}, {"status": "Ongoing", "city": "Northfield", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "97811", "recalling_firm": "Medline Industries, LP", "address_1": "3 Lakes Dr", "address_2": "", "postal_code": "60093-2753", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0035-2026", "product_description": "Medline, Alcohol Prep Pads (2-Ply Pad, 70% Isopropyl Alcohol), 100 eaches per box, 10 boxes per case (1,000 eaches per case), Single Use Only, Manufactured for Medline Industries, LP, Three Lakes Drive, Northfield, IL, 60093 USA, NDC 55329-811-30.", "product_quantity": "222,800 eaches", "reason_for_recall": "Subpotent Drug", "recall_initiation_date": "20250929", "center_classification_date": "20251021", "report_date": "20251029", "code_info": "Lot #: 61224040057", "more_code_info": ""}, {"status": "Ongoing", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96308", "recalling_firm": "Safecor Health, LLC", "address_1": "4060 Business Park Dr Ste B", "address_2": "", "postal_code": "43204-5047", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0253-2025", "product_description": "Lorazepam 0.5 mg per 0.25 mL Oral Syringe, Delivers: 0.25 mL, Oral Concentrate, Rx Only, Refrigerate, Mfg by: PAI, Pkg by: Safecor Health, LLC, Columbus, OH 43204, NDC: a) 00054353244, b) 00121077001, c) 65162068784.", "product_quantity": "3465 Oral Syringes", "reason_for_recall": "Defective Delivery System: Leakage observed after oral solution was repackaged into unit-dose syringes.", "recall_initiation_date": "20250217", "center_classification_date": "20250305", "report_date": "20250312", "code_info": "Lot #s:  a) 24210274, Exp 01/31/2025; 24401700, Exp 04/25/2025;  b) 24251067, Exp 03/25/2025; 24421733, Exp 06/03/2025;  c) 24261384, Exp 03/24/2025; 24370127, Exp 04/28/2025.", "more_code_info": ""}, {"status": "Ongoing", "city": "Fayetteville", "state": "AR", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "96706", "recalling_firm": "OurPharma LLC", "address_1": "2512 S City Lake Rd", "address_2": "N/A", "postal_code": "72701-5013", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0385-2025", "product_description": "HYDROmorphone Hydrochloride 50mg/50mL (1mg/mL), packaged in a 50 mL Cassette, Rx Only, OurPharma, LLC, 2512 S. City Lake Rd., Fayetteville, AR 72701,  NDC 73013-1040-01.", "product_quantity": "1,375 cassettes", "reason_for_recall": "Superpotent Drug: Assay/potency result for hydromorphone HCl in the compounded stability lot was higher than specification..", "recall_initiation_date": "20250415", "center_classification_date": "20250421", "report_date": "20250430", "code_info": "104024120001, Exp Date 06/01/2025; 104024120002, Exp Date 06/21/2025; 104025010001, Exp Date 07/13/2025; 104025010002, Exp Date 07/28/2025"}, {"status": "Ongoing", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96308", "recalling_firm": "Safecor Health, LLC", "address_1": "4060 Business Park Dr Ste B", "address_2": "", "postal_code": "43204-5047", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0252-2025", "product_description": "Ferrous Sulfate 7.5 mg Iron/0.5 mL Oral Syringe, Delivers: 0.5 mL, Iron Supplement Drops, Mfg by: Akron Pharma, Pkg by: Safecor, Columbus, OH 43204.  NDC: a) 71399748005, b) 39328055750, c) 69618007059.", "product_quantity": "1535 Oral Syringes", "reason_for_recall": "Defective Delivery System: Leakage observed after oral solution was repackaged into unit-dose syringes.", "recall_initiation_date": "20250217", "center_classification_date": "20250305", "report_date": "20250312", "code_info": "Lot #s:  a) 24250093, Exp 03/07/2025; 24321592, Exp 04/04/2025; 24280320, Exp 03/27/2025;  b) 24371268, Exp 04/19/2025;  c) 24400519, Exp 04/07/2025; 24500768, Exp 06/24/2025; 25040972, Exp 07/25/2025.", "more_code_info": ""}, {"status": "Ongoing", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95953", "recalling_firm": "Amerisource Health Services LLC", "address_1": "2550 John Glenn Ave Ste A", "address_2": "", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0157-2025", "product_description": "Duloxetine Delayed-Release Capsules USP, 60 mg, Rx only, 30 count bottles, Manufactured by: Aurobindo Pharma Limited, Hyderabad-500 090, India, For BluePoint Laboratories NDC 68001-415-04", "product_quantity": "20,734 30-count bottles", "reason_for_recall": "CGMP Deviations: Presence of N-nitroso-duloxetine impurity above the recommended interim limit.", "recall_initiation_date": "20241206", "center_classification_date": "20241223", "report_date": "20250101", "code_info": "Lot DT6023061B Exp 01/31/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Cremorne", "state": "N/A", "country": "Australia", "classification": "Class II", "openfda": {"application_number": ["M020"], "brand_name": ["ULTRA VIOLETTE MINI MATES"], "generic_name": ["SPF 50"], "manufacturer_name": ["Grace And Fire USA Inc."], "product_ndc": ["84803-110"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "spl_id": ["2a70f6df-22e6-20bb-e063-6394a90a3a66"], "spl_set_id": ["27e377c2-1e68-d4e2-e063-6394a90a2812"], "package_ndc": ["84803-110-01", "84803-106-01", "84803-100-15", "9355909005"], "is_original_packager": [true]}, "product_type": "Drugs", "event_id": "97498", "recalling_firm": "GRACE & FIRE PTY LTD", "address_1": "19 Dover Street", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0641-2025", "product_description": "Ultra Violette Mini SPF Mates kit includes: Velvet Screen SPF 50 Blurring Mineral SkinScreen, Zinc Oxide 22.75%, 15 mL, 0.5 fl. oz. per tube, Supreme Sunscreen SPF 50,  15 mL 0.5 fl. oz. per tube, Distributed by: Grace & Fire USA Inc., 251 Little Falls Drive, New Castle Wilmington, Delaware 19808, NDC 84803-110-01 (15 mL Velvet Screen), UPC 9355909005757.", "product_quantity": "44,497 tubes", "reason_for_recall": "Subpotent/Super-potent Product: Testing of the SPF 50 sunscreen revealed inconsistency in SPF results ranging from SPF 4, 10, 21, 26, 33, 60, 61, and 64.", "recall_initiation_date": "20250822", "center_classification_date": "20250911", "report_date": "20250917", "code_info": "Lot #s: A2453, exp 11/30/2026; A2454, exp 12/31/2026"}, {"status": "Ongoing", "city": "Newtown", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA079175"], "brand_name": ["INDOMETHACIN"], "generic_name": ["INDOMETHACIN"], "manufacturer_name": ["KVK-Tech, Inc."], "product_ndc": ["10702-016"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["INDOMETHACIN"], "rxcui": ["310992"], "spl_id": ["30a4fdec-3f89-034c-e063-6294a90aa786"], "spl_set_id": ["dc80228c-acae-44dc-9762-19bd1669bf45"], "package_ndc": ["10702-016-03", "10702-016-06", "10702-016-09", "10702-016-01", "10702-016-50", "10702-016-10"], "is_original_packager": [true], "upc": ["0310702016101", "0310702016033"], "nui": ["N0000000160", "M0001335", "N0000175722"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]"], "unii": ["XXE1CET956"]}, "product_type": "Drugs", "event_id": "96847", "recalling_firm": "KVK Tech, Inc.", "address_1": "110 Terry Dr", "address_2": "N/A", "postal_code": "18940-3427", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-0445-2025", "product_description": "Indomethacin Extended-Release Capsules USP, 75 mg, 100-count bottle, Rx only, Mfd. By: KVK-Tech, Inc., Newtown, PA, 18940, Made in USA, NDC 10702-016-01.", "product_quantity": "9107 bottles", "reason_for_recall": "cGMP deviations", "recall_initiation_date": "20250509", "center_classification_date": "20250521", "report_date": "20250528", "code_info": "Lot#: 18400A, Exp 7/31/2027"}, {"status": "Ongoing", "city": "Elmsford", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96981", "recalling_firm": "Advanced Pharmaceutical Technology, Inc.", "address_1": "132 S Central Ave", "address_2": "", "postal_code": "10523-3509", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "NY, NJ", "recall_number": "D-0531-2025", "product_description": "TESTO-200, Testosterone Cypionate Inj. USP, 2000mg/10ml (200mg/ml), One 10ml multidose vial per carton, For intramuscular injection only, Rx Only, ADVANCED PHARMACEUTICAL TECHNOLOGY, INC., 132 South Central Avenue, Elmsford, NY 10523.  NDC 57377-200-01", "product_quantity": "26 vials", "reason_for_recall": "Marketed Without an Approved NDA/ANDA", "recall_initiation_date": "20250530", "center_classification_date": "20250716", "report_date": "20250702", "code_info": "Lot P-24-1; Exp. 02/28/2027", "more_code_info": ""}, {"status": "Ongoing", "city": "East Windsor", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M013"], "brand_name": ["AMAZON BASIC CARE ACETAMINOPHEN"], "generic_name": ["ACETAMINOPHEN"], "manufacturer_name": ["Amazon.com Services LLC"], "product_ndc": ["72288-405"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["ACETAMINOPHEN"], "rxcui": ["313782"], "spl_id": ["750d7098-eaaf-4d08-a673-fb86c5ced186"], "spl_set_id": ["113d92bf-f6c9-cc3d-e063-6294a90af033"], "package_ndc": ["72288-405-10"], "is_original_packager": [true], "upc": ["0195515048866"], "unii": ["362O9ITL9D"]}, "product_type": "Drugs", "event_id": "96907", "recalling_firm": "Aurobindo Pharma USA Inc", "address_1": "279 Princeton Hightstown Rd", "address_2": "N/A", "postal_code": "08520-1401", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "USA Nationwide.", "recall_number": "D-0471-2025", "product_description": "Acetaminophen Tablets, 325 mg, 100-count bottles, Distributed by: Amazon.com Services LLC, 410 Terry Avenue N., Seattle, WA 98109, NDC 72288-405-10", "product_quantity": "4,608 bottles", "reason_for_recall": "cGMP deviations: Due to confirmed consumer complaints received with the observation of tablet discoloration (brown surface on tablets).", "recall_initiation_date": "20250522", "center_classification_date": "20250617", "report_date": "20250625", "code_info": "Lot#: AEF124004A, Exp date 08/31/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA205075"], "brand_name": ["RUFINAMIDE"], "generic_name": ["RUFINAMIDE"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-713", "68462-714"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["RUFINAMIDE"], "rxcui": ["824295", "824301"], "spl_id": ["087abf2a-9b50-469c-ac8b-5d3eb98c3b62"], "spl_set_id": ["da9ee326-a383-4d46-9d4e-fcc2be3d2680"], "package_ndc": ["68462-713-30", "68462-713-08", "68462-713-05", "68462-714-08", "68462-714-05"], "is_original_packager": [true], "upc": ["0368462713082", "0368462714089"], "unii": ["WFW942PR79"]}, "product_type": "Drugs", "event_id": "96474", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0323-2025", "product_description": "Rufinamide Tablets 200mg, 120-count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India, Manufactured for: Glenmark Pharmaceuticals Inc. USA, Mahwah, NJ 07430. NDC# 68462-713-08", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250313", "center_classification_date": "20250408", "report_date": "20250416", "code_info": "Lot #  17231643, exp. date Jul-25 17231644, exp. date Jul-25"}, {"status": "Ongoing", "city": "Fairfield", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "95944", "recalling_firm": "Akron Pharma, Inc.", "address_1": "373 Us Highway 46 Ste 117", "address_2": "", "postal_code": "07004-2456", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0194-2025", "product_description": "Acetaminophen Regular Strength, 325 mg, 100 Tablets per bottle, Akron Pharma, Inc., 373 RT US 46 W Building E, Suite 117, Fairfield, NJ 07004, NDC 71399-8024-01 .", "product_quantity": "6429 bottles", "reason_for_recall": "Labeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.", "recall_initiation_date": "20241212", "center_classification_date": "20250110", "report_date": "20250122", "code_info": "Lot #: KDT0124001, Exp 08/31/2026", "more_code_info": ""}]